Epidemiology of epithelial ovarian cancer
Globally, ovarian cancer is the seventh most common cancer in women and the eighth most common cause of cancer death, with five-year survival rates below 45%. Although age-standardised rates are stable or falling in most high-income countries, they are rising in many low and middle income countries....
Saved in:
| Published in | Best practice & research. Clinical obstetrics & gynaecology Vol. 41; pp. 3 - 14 |
|---|---|
| Main Authors | , |
| Format | Journal Article |
| Language | English |
| Published |
Netherlands
Elsevier Ltd
01.05.2017
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 1521-6934 1532-1932 1532-1932 |
| DOI | 10.1016/j.bpobgyn.2016.08.006 |
Cover
| Abstract | Globally, ovarian cancer is the seventh most common cancer in women and the eighth most common cause of cancer death, with five-year survival rates below 45%. Although age-standardised rates are stable or falling in most high-income countries, they are rising in many low and middle income countries. Furthermore, with increasing life-expectancy, the number of cases diagnosed each year is increasing. To control ovarian cancer we need to understand the causes. This will allow better prediction of those at greatest risk for whom screening might be appropriate, while identification of potentially modifable causes provides an opportunity for intervention to reduce rates. In this paper we will summarise the current state of knowledge regarding the known and possible causes of epithelial ovarian cancer and discuss some of the main theories of ovarian carcinogenesis. We will also briefly review the relationship between lifestyle and survival after a diagnosis of ovarian cancer.
•Ovarian cancer is a major cause of mortality and case numbers are increasing.•Five-year relative survival is below 45%.•Reproductive exposures strongly influence risk but are not readily modifiable.•Modifiable lifestyle factors have small effects or only affect risk of some histotypes.•Little is known about the relation between lifestyle and ovarian cancer survival. |
|---|---|
| AbstractList | Globally, ovarian cancer is the seventh most common cancer in women and the eighth most common cause of cancer death, with five-year survival rates below 45%. Although age-standardised rates are stable or falling in most high-income countries, they are rising in many low and middle income countries. Furthermore, with increasing life-expectancy, the number of cases diagnosed each year is increasing. To control ovarian cancer we need to understand the causes. This will allow better prediction of those at greatest risk for whom screening might be appropriate, while identification of potentially modifable causes provides an opportunity for intervention to reduce rates. In this paper we will summarise the current state of knowledge regarding the known and possible causes of epithelial ovarian cancer and discuss some of the main theories of ovarian carcinogenesis. We will also briefly review the relationship between lifestyle and survival after a diagnosis of ovarian cancer.
•Ovarian cancer is a major cause of mortality and case numbers are increasing.•Five-year relative survival is below 45%.•Reproductive exposures strongly influence risk but are not readily modifiable.•Modifiable lifestyle factors have small effects or only affect risk of some histotypes.•Little is known about the relation between lifestyle and ovarian cancer survival. Abstract Globally, ovarian cancer is the seventh most common cancer in women and the eighth most common cause of cancer death, with five-year survival rates below 45%. Although age-standardised rates are stable or falling in most high-income countries, they are rising in many low and middle income countries. Furthermore, with increasing life-expectancy, the number of cases diagnosed each year is increasing. To control ovarian cancer we need to understand the causes. This will allow better prediction of those at greatest risk for whom screening might be appropriate, while identification of potentially modifable causes provides an opportunity for intervention to reduce rates. In this paper we will summarise the current state of knowledge regarding the known and possible causes of epithelial ovarian cancer and discuss some of the main theories of ovarian carcinogenesis. We will also briefly review the relationship between lifestyle and survival after a diagnosis of ovarian cancer. Globally, ovarian cancer is the seventh most common cancer in women and the eighth most common cause of cancer death, with five-year survival rates below 45%. Although age-standardised rates are stable or falling in most high-income countries, they are rising in many low and middle income countries. Furthermore, with increasing life-expectancy, the number of cases diagnosed each year is increasing. To control ovarian cancer we need to understand the causes. This will allow better prediction of those at greatest risk for whom screening might be appropriate, while identification of potentially modifable causes provides an opportunity for intervention to reduce rates. In this paper we will summarise the current state of knowledge regarding the known and possible causes of epithelial ovarian cancer and discuss some of the main theories of ovarian carcinogenesis. We will also briefly review the relationship between lifestyle and survival after a diagnosis of ovarian cancer.Globally, ovarian cancer is the seventh most common cancer in women and the eighth most common cause of cancer death, with five-year survival rates below 45%. Although age-standardised rates are stable or falling in most high-income countries, they are rising in many low and middle income countries. Furthermore, with increasing life-expectancy, the number of cases diagnosed each year is increasing. To control ovarian cancer we need to understand the causes. This will allow better prediction of those at greatest risk for whom screening might be appropriate, while identification of potentially modifable causes provides an opportunity for intervention to reduce rates. In this paper we will summarise the current state of knowledge regarding the known and possible causes of epithelial ovarian cancer and discuss some of the main theories of ovarian carcinogenesis. We will also briefly review the relationship between lifestyle and survival after a diagnosis of ovarian cancer. Globally, ovarian cancer is the seventh most common cancer in women and the eighth most common cause of cancer death, with five-year survival rates below 45%. Although age-standardised rates are stable or falling in most high-income countries, they are rising in many low and middle income countries. Furthermore, with increasing life-expectancy, the number of cases diagnosed each year is increasing. To control ovarian cancer we need to understand the causes. This will allow better prediction of those at greatest risk for whom screening might be appropriate, while identification of potentially modifable causes provides an opportunity for intervention to reduce rates. In this paper we will summarise the current state of knowledge regarding the known and possible causes of epithelial ovarian cancer and discuss some of the main theories of ovarian carcinogenesis. We will also briefly review the relationship between lifestyle and survival after a diagnosis of ovarian cancer. |
| Author | Jordan, Susan J. Webb, Penelope M. |
| Author_xml | – sequence: 1 givenname: Penelope M. orcidid: 0000-0003-0733-5930 surname: Webb fullname: Webb, Penelope M. email: penny.webb@qimrberghofer.edu.au organization: QIMR Berghofer Medical Research Institute, Locked Bag 2000 Royal Brisbane Hospital, Brisbane, Queensland 4029, Australia – sequence: 2 givenname: Susan J. surname: Jordan fullname: Jordan, Susan J. email: susan.jordan@qimrberghofer.edu.au organization: QIMR Berghofer Medical Research Institute, Locked Bag 2000 Royal Brisbane Hospital, Brisbane, Queensland 4029, Australia |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27743768$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNUV1rFDEUDdJi29WfoOyjPuw0X5PJIFaktLVQ6IP6HDLJTc2aTcZktrD_3gy7fSlIfckHnHPuPeecoaOYIiD0juCGYCLO180wpuFhFxtavw2WDcbiFTolLaMr0jN6NL8pWYme8RN0VsoaY8Z62r5GJ7TrOOuEPEUfr0ZvYeNTSA-7ZXJLGP30C4LXYZkedfY6Lo2OBvIbdOx0KPD2cC_Qz-urH5ffVnf3N7eXX-9Whnd8qqdsDa5b8E5TJjljTlBitRNWMmq5GXpnqGXtwAYDtpMSnHWUCMIdFQNjC_Rhrzvm9GcLZVIbXwyEoCOkbVFEspYzzqqvBXp_gG6HDVg1Zr_Reaee7FXApz3A5FRKBqeMn_TkU5yy9kERrOYw1VodwlRzmApLVcOs7PYZ-2nAS7wvex7UmB49ZFWMh5qh9RnMpGzyLypcPFMwwUdvdPgNOyjrtM2xdqCIKlRh9X0ueu6ZCIZxT2bjn_8t8B8L_AVrz7nn |
| CitedBy_id | crossref_primary_10_1007_s11033_024_09464_y crossref_primary_10_29039_rusjbpc_2023_0590 crossref_primary_10_1038_s41416_022_02097_7 crossref_primary_10_1186_s12885_018_4970_9 crossref_primary_10_1007_s00404_021_06342_x crossref_primary_10_1002_cbin_11459 crossref_primary_10_1016_j_ijgc_2024_101617 crossref_primary_10_1016_j_ijbiomac_2024_135079 crossref_primary_10_1016_j_jmig_2017_01_001 crossref_primary_10_1016_j_soncn_2018_12_001 crossref_primary_10_1155_2022_7599098 crossref_primary_10_1016_j_cellsig_2024_111441 crossref_primary_10_1080_15685551_2022_2033432 crossref_primary_10_1016_j_biocel_2019_105617 crossref_primary_10_1016_j_jconrel_2019_08_034 crossref_primary_10_1080_15384047_2019_1595278 crossref_primary_10_1080_21655979_2021_2003662 crossref_primary_10_18632_aging_203645 crossref_primary_10_4196_kjpp_2023_27_1_31 crossref_primary_10_1002_jcp_29028 crossref_primary_10_1016_j_jddst_2024_105643 crossref_primary_10_1016_j_bbrc_2019_12_050 crossref_primary_10_1200_JCO_22_00751 crossref_primary_10_1016_j_repbio_2022_100702 crossref_primary_10_1111_jog_14302 crossref_primary_10_1042_BSR20203089 crossref_primary_10_3390_ijms21072619 crossref_primary_10_1166_jbt_2021_2750 crossref_primary_10_1007_s40944_025_00978_2 crossref_primary_10_1016_j_intimp_2024_112876 crossref_primary_10_1016_j_ygyno_2021_03_028 crossref_primary_10_1111_cpr_13578 crossref_primary_10_1007_s12672_024_01404_3 crossref_primary_10_1038_s41598_024_52117_0 crossref_primary_10_1186_s12935_022_02756_y crossref_primary_10_1016_j_lfs_2020_118670 crossref_primary_10_1186_s13048_021_00876_z crossref_primary_10_1371_journal_pone_0274802 crossref_primary_10_1186_s12905_024_02881_y crossref_primary_10_18632_aging_203773 crossref_primary_10_3892_ol_2020_11487 crossref_primary_10_17749_2313_7347_2019_13_4_345_353 crossref_primary_10_1177_0300985820971752 crossref_primary_10_3389_fonc_2022_1037796 crossref_primary_10_3389_fonc_2022_839508 crossref_primary_10_2478_amb_2025_0006 crossref_primary_10_1097_CAD_0000000000000858 crossref_primary_10_1590_1678_4685_gmb_2021_0224 crossref_primary_10_3389_fonc_2022_917471 crossref_primary_10_3892_mco_2024_2804 crossref_primary_10_3390_cancers13133349 crossref_primary_10_3390_ijms20112750 crossref_primary_10_1111_jog_15404 crossref_primary_10_1158_1541_7786_MCR_19_0449 crossref_primary_10_1016_j_gore_2021_100777 crossref_primary_10_1136_ijgc_2018_000066 crossref_primary_10_3892_etm_2021_9674 crossref_primary_10_1016_j_ygyno_2020_09_041 crossref_primary_10_3389_fonc_2022_868061 crossref_primary_10_3389_fcell_2024_1459183 crossref_primary_10_1042_BSR20200800 crossref_primary_10_3390_medicina58121706 crossref_primary_10_2147_IJGM_S302012 crossref_primary_10_3390_cancers14092230 crossref_primary_10_3389_fgene_2022_905238 crossref_primary_10_1155_2021_8032209 crossref_primary_10_1186_s12885_024_12434_z crossref_primary_10_1016_j_neo_2024_101037 crossref_primary_10_2147_OTT_S272752 crossref_primary_10_1093_jpp_rgad030 crossref_primary_10_1007_s13167_019_00175_0 crossref_primary_10_5306_wjco_v16_i1_94813 crossref_primary_10_1007_s11523_019_00650_8 crossref_primary_10_1210_endocr_bqac141 crossref_primary_10_1002_14651858_CD007697_pub3 crossref_primary_10_3389_fgene_2020_566497 crossref_primary_10_1186_s12889_024_18437_6 crossref_primary_10_1186_s13048_021_00877_y crossref_primary_10_1186_s12885_025_13527_z crossref_primary_10_2147_CMAR_S237726 crossref_primary_10_3389_fonc_2021_725264 crossref_primary_10_3389_fendo_2022_972341 crossref_primary_10_1155_2022_1091042 crossref_primary_10_2147_CMAR_S385658 crossref_primary_10_1007_s00761_018_0363_6 crossref_primary_10_1186_s41065_022_00222_3 crossref_primary_10_5483_BMBRep_2020_53_6_060 crossref_primary_10_1016_j_jddst_2024_105755 crossref_primary_10_5005_jp_journals_10009_1702 crossref_primary_10_1016_j_phymed_2022_154401 crossref_primary_10_1002_ijgo_15837 crossref_primary_10_1186_s12967_022_03422_7 crossref_primary_10_2147_IJWH_S473381 crossref_primary_10_1111_cpr_13029 crossref_primary_10_12688_f1000research_126337_1 crossref_primary_10_1038_s41419_022_05286_7 crossref_primary_10_3389_fonc_2022_952425 crossref_primary_10_1016_j_intimp_2023_110143 crossref_primary_10_1038_s41598_020_77532_x crossref_primary_10_1007_s12032_025_02621_8 crossref_primary_10_2217_epi_2020_0097 crossref_primary_10_1016_j_cbi_2021_109780 crossref_primary_10_1016_j_jgg_2018_03_001 crossref_primary_10_3390_ijerph191710516 crossref_primary_10_2147_IJN_S362263 crossref_primary_10_31083_j_ceog4902035 crossref_primary_10_1111_jog_15714 crossref_primary_10_1371_journal_pone_0290031 crossref_primary_10_3389_fphys_2022_1054508 crossref_primary_10_3390_genes14040785 crossref_primary_10_1111_joim_12747 crossref_primary_10_1002_1878_0261_12893 crossref_primary_10_1002_ijc_31750 crossref_primary_10_2147_CMAR_S274807 crossref_primary_10_1016_j_gore_2021_100880 crossref_primary_10_1186_s13048_021_00896_9 crossref_primary_10_1002_mco2_34 crossref_primary_10_1097_MD_0000000000023849 crossref_primary_10_1089_scd_2017_0153 crossref_primary_10_3389_fonc_2019_00421 crossref_primary_10_1038_s41417_023_00659_2 crossref_primary_10_1080_14796694_2024_2386922 crossref_primary_10_1007_s00404_021_06138_z crossref_primary_10_3390_cells11060964 crossref_primary_10_1016_j_jogoh_2022_102344 crossref_primary_10_4103_ijmr_IJMR_1160_19 crossref_primary_10_1016_j_ejogrb_2021_11_013 crossref_primary_10_1038_s41571_024_00881_3 crossref_primary_10_3390_jcm12237372 crossref_primary_10_3390_ijms22073495 crossref_primary_10_23736_S2724_5691_21_09283_2 crossref_primary_10_3390_biomedicines9010055 crossref_primary_10_1016_j_nano_2023_102686 crossref_primary_10_62347_ECOO9552 crossref_primary_10_1038_s41417_023_00625_y crossref_primary_10_1016_j_intimp_2023_110162 crossref_primary_10_1186_s13048_024_01413_4 crossref_primary_10_1080_01635581_2018_1380203 crossref_primary_10_3389_fcell_2022_1115786 crossref_primary_10_18632_aging_102538 crossref_primary_10_1248_bpb_b22_00780 crossref_primary_10_1002_ar_24367 crossref_primary_10_1590_1414_431x2021e11183 crossref_primary_10_1093_jn_nxab011 crossref_primary_10_1089_cbr_2020_4444 crossref_primary_10_3389_fimmu_2023_1182677 crossref_primary_10_3390_informatics11040095 crossref_primary_10_1016_j_critrevonc_2022_103852 crossref_primary_10_3390_cancers16162828 crossref_primary_10_2478_acb_2021_0019 crossref_primary_10_1016_j_ygyno_2022_12_009 crossref_primary_10_1007_s00011_021_01495_6 crossref_primary_10_3389_fimmu_2022_1007326 crossref_primary_10_1016_j_jim_2022_113229 crossref_primary_10_1097_CAD_0000000000001406 crossref_primary_10_1016_j_heliyon_2024_e35202 crossref_primary_10_1016_j_ygyno_2020_07_008 crossref_primary_10_1166_jbn_2022_3303 crossref_primary_10_1007_s43032_023_01188_x crossref_primary_10_1016_j_virol_2020_10_009 crossref_primary_10_1186_s13048_020_00672_1 crossref_primary_10_1007_s10815_021_02177_2 crossref_primary_10_3390_ijms22084243 crossref_primary_10_1080_01635581_2021_1952626 crossref_primary_10_1002_ijc_33727 crossref_primary_10_1016_j_jtcme_2021_03_005 crossref_primary_10_2139_ssrn_4100276 crossref_primary_10_1155_2021_8388258 crossref_primary_10_1186_s12935_023_03170_8 crossref_primary_10_1097_MD_0000000000026895 crossref_primary_10_3928_25731777_20241213_07 crossref_primary_10_3390_pharmaceutics16050664 crossref_primary_10_1155_2023_5223657 crossref_primary_10_3389_fonc_2025_1540734 crossref_primary_10_1002_cam4_5415 crossref_primary_10_1016_j_imbio_2024_152863 crossref_primary_10_1007_s11523_021_00842_1 crossref_primary_10_3390_cancers13163976 crossref_primary_10_3389_fonc_2022_987169 crossref_primary_10_1038_s41598_023_35572_z crossref_primary_10_1186_s12967_021_02781_x crossref_primary_10_1016_j_canlet_2021_12_029 crossref_primary_10_20517_mrr_2023_51 crossref_primary_10_1002_fsn3_2621 crossref_primary_10_3389_fmolb_2022_915409 crossref_primary_10_1186_s12885_022_09887_5 crossref_primary_10_1016_j_hpr_2024_300754 crossref_primary_10_1021_acs_jmedchem_2c00737 crossref_primary_10_1177_1724600819850178 crossref_primary_10_1007_s12325_021_01941_1 crossref_primary_10_1055_s_0044_1789581 crossref_primary_10_3389_fonc_2021_744256 crossref_primary_10_4236_ojog_2023_1312168 crossref_primary_10_3389_fonc_2021_704001 crossref_primary_10_30699_jogcr_3_2_59 crossref_primary_10_1098_rsob_190173 crossref_primary_10_1126_sciadv_ade6958 crossref_primary_10_31083_j_ceog5105118 crossref_primary_10_2174_1874467212666191022102800 crossref_primary_10_7759_cureus_9232 crossref_primary_10_1016_j_mcp_2022_101871 crossref_primary_10_3390_pharmaceutics11100547 crossref_primary_10_1016_j_arcmed_2020_11_008 crossref_primary_10_12677_ACM_2021_116380 crossref_primary_10_3892_wasj_2025_316 crossref_primary_10_3390_pharmaceutics15030948 crossref_primary_10_1186_s12935_020_01406_5 crossref_primary_10_1007_s10528_022_10232_5 crossref_primary_10_1007_s00262_022_03305_2 crossref_primary_10_1039_C8RA03274B crossref_primary_10_1016_j_ejogrb_2025_02_057 crossref_primary_10_1016_j_jare_2022_04_006 crossref_primary_10_1111_cas_15627 crossref_primary_10_3390_antiox10101583 crossref_primary_10_3389_fonc_2022_968547 crossref_primary_10_1259_bjr_20201441 crossref_primary_10_1155_2021_7624346 crossref_primary_10_3390_nu11102523 crossref_primary_10_1111_phn_13390 crossref_primary_10_3389_fonc_2021_732058 crossref_primary_10_1080_13880209_2023_2166965 crossref_primary_10_1089_ars_2023_0400 crossref_primary_10_3389_fonc_2022_1003710 crossref_primary_10_1111_jog_15019 crossref_primary_10_3390_cimb45020081 crossref_primary_10_23736_S0026_4806_19_06086_5 crossref_primary_10_1016_j_prp_2022_154215 crossref_primary_10_1097_LBR_0000000000000463 crossref_primary_10_1186_s13048_020_00640_9 crossref_primary_10_4103_jcrt_jcrt_517_22 crossref_primary_10_3390_genes14040886 crossref_primary_10_1515_med_2017_0020 crossref_primary_10_3390_cancers13010004 crossref_primary_10_1186_s13048_021_00808_x crossref_primary_10_3390_ijms20082053 crossref_primary_10_1186_s12938_024_01219_x crossref_primary_10_1016_j_eujim_2020_101163 crossref_primary_10_19161_etd_669376 crossref_primary_10_1007_s11912_020_0873_4 crossref_primary_10_1038_s41417_021_00306_8 crossref_primary_10_12998_wjcc_v9_i18_4644 crossref_primary_10_3390_ijms21134813 crossref_primary_10_1016_j_drudis_2023_103666 crossref_primary_10_3389_fpubh_2021_619581 crossref_primary_10_1080_10942912_2023_2246678 crossref_primary_10_1155_2019_9037197 crossref_primary_10_3390_ijms26051857 crossref_primary_10_1007_s00432_023_04769_0 crossref_primary_10_3390_cancers15184651 crossref_primary_10_1093_jrr_rrad033 crossref_primary_10_3389_fcell_2021_701429 crossref_primary_10_3389_fsurg_2025_1443605 crossref_primary_10_1042_BSR20201431 crossref_primary_10_1111_jfbc_13278 crossref_primary_10_1007_s12032_021_01501_1 crossref_primary_10_1016_j_acra_2022_12_019 crossref_primary_10_1080_15384101_2022_2109362 crossref_primary_10_3390_molecules26061659 crossref_primary_10_1016_j_biopha_2024_117335 crossref_primary_10_21020_husbfd_1083740 crossref_primary_10_1111_pin_13488 crossref_primary_10_1111_jcmm_15553 crossref_primary_10_3389_fimmu_2022_943389 crossref_primary_10_3390_life14040530 crossref_primary_10_3390_cancers13081875 crossref_primary_10_3390_pharmaceutics11050219 crossref_primary_10_1080_08830185_2022_2102619 crossref_primary_10_3389_fphar_2020_00150 crossref_primary_10_1177_22840265241240212 crossref_primary_10_3389_fonc_2019_00954 crossref_primary_10_3892_mmr_2022_12866 crossref_primary_10_1097_MS9_0000000000001914 crossref_primary_10_1016_j_esmoop_2021_100149 crossref_primary_10_1111_jog_15433 crossref_primary_10_1002_uog_23530 crossref_primary_10_1155_2020_7263602 crossref_primary_10_1016_j_biochi_2025_03_002 crossref_primary_10_1016_j_ijpharm_2020_120079 crossref_primary_10_4103_1735_5362_394820 crossref_primary_10_1038_s41416_020_0849_z crossref_primary_10_1016_j_ejso_2021_03_239 crossref_primary_10_3389_fonc_2024_1503107 crossref_primary_10_1111_1440_1681_13466 crossref_primary_10_1002_cam4_2350 crossref_primary_10_1038_s41419_023_06084_5 crossref_primary_10_1186_s12885_024_12385_5 crossref_primary_10_1016_j_ygyno_2022_03_005 crossref_primary_10_3892_mco_2023_2712 crossref_primary_10_12677_ACM_2021_114284 crossref_primary_10_1111_jog_15798 crossref_primary_10_3390_curroncol30110688 crossref_primary_10_1007_s40944_019_0342_x crossref_primary_10_1530_REP_17_0687 crossref_primary_10_3390_app10134446 crossref_primary_10_1016_j_ygyno_2022_10_010 crossref_primary_10_36106_ijsr_3706376 crossref_primary_10_3389_fonc_2022_991769 crossref_primary_10_1515_pteridines_2019_0020 crossref_primary_10_1016_j_tranon_2020_100987 crossref_primary_10_1007_s00432_023_05466_8 crossref_primary_10_1016_j_bioorg_2023_106657 crossref_primary_10_1155_2021_5579543 crossref_primary_10_1158_1541_7786_MCR_22_0139 crossref_primary_10_1002_cnr2_1976 crossref_primary_10_1177_02841851241262520 crossref_primary_10_1155_2022_4655939 crossref_primary_10_1002_kjm2_12393 crossref_primary_10_3389_fonc_2023_1152991 crossref_primary_10_3389_fmolb_2023_1165781 crossref_primary_10_1186_s13048_021_00938_2 crossref_primary_10_1080_15384101_2019_1634946 crossref_primary_10_1166_jbt_2021_2410 crossref_primary_10_1002_ijc_34403 crossref_primary_10_1080_15384101_2021_1963910 crossref_primary_10_3389_fphar_2023_1194719 crossref_primary_10_3390_proteomes12010008 crossref_primary_10_3390_molecules22101717 crossref_primary_10_1016_j_aej_2024_05_079 crossref_primary_10_1016_j_critrevonc_2024_104465 crossref_primary_10_1158_1055_9965_EPI_23_0984 crossref_primary_10_1155_2021_6680036 crossref_primary_10_3390_jcm13061546 crossref_primary_10_32604_biocell_2021_012137 crossref_primary_10_1371_journal_pone_0317502 crossref_primary_10_1155_2022_4664651 crossref_primary_10_1186_s13048_021_00783_3 crossref_primary_10_3390_medicina57060561 crossref_primary_10_1186_s13000_023_01340_w crossref_primary_10_1136_bmjopen_2021_051037 crossref_primary_10_1155_2022_5988310 crossref_primary_10_1080_0284186X_2022_2066985 crossref_primary_10_3390_cancers17020240 crossref_primary_10_31083_j_ceog4908173 crossref_primary_10_1016_j_ijscr_2022_107111 crossref_primary_10_2147_CMAR_S330368 crossref_primary_10_3389_fmolb_2024_1361601 crossref_primary_10_1515_pp_2020_0137 crossref_primary_10_1016_j_ygyno_2024_12_007 crossref_primary_10_1515_pteridines_2022_0043 crossref_primary_10_1186_s12935_020_01551_x crossref_primary_10_1016_j_mcpro_2023_100520 crossref_primary_10_3892_etm_2019_8282 crossref_primary_10_1007_s00261_023_03957_3 crossref_primary_10_3390_ijms22147359 crossref_primary_10_1002_mc_23856 crossref_primary_10_1186_s12906_024_04431_3 crossref_primary_10_3389_fmed_2024_1334062 crossref_primary_10_3892_or_2021_8174 crossref_primary_10_3390_ijms24021768 crossref_primary_10_1136_ijgc_2023_004894 crossref_primary_10_1021_acs_molpharmaceut_2c00557 crossref_primary_10_31083_j_fbl2707210 crossref_primary_10_32604_biocell_2021_012516 crossref_primary_10_3390_jcm11195627 crossref_primary_10_2174_1389201022666210810090728 crossref_primary_10_1007_s13258_024_01517_7 crossref_primary_10_2298_VSP231201024G crossref_primary_10_1007_s13402_023_00859_w crossref_primary_10_1016_j_jconrel_2021_02_032 crossref_primary_10_1016_j_biopha_2021_111536 crossref_primary_10_1016_j_biopha_2023_115344 crossref_primary_10_2174_1386207326666230627114111 crossref_primary_10_1016_j_heliyon_2020_e05442 crossref_primary_10_5937_KgJSci2345121P crossref_primary_10_1016_j_nano_2020_102258 crossref_primary_10_3390_antiox9111137 crossref_primary_10_1002_mco2_697 crossref_primary_10_3892_etm_2021_10754 crossref_primary_10_3389_fonc_2021_690618 crossref_primary_10_1002_1878_0261_13076 crossref_primary_10_1016_j_disamonth_2024_101691 crossref_primary_10_1016_j_ejogrb_2023_11_017 crossref_primary_10_2147_IJGM_S450976 crossref_primary_10_1016_j_cell_2020_01_009 crossref_primary_10_1007_s00404_022_06466_8 crossref_primary_10_1016_j_clinbiochem_2023_110615 crossref_primary_10_1002_ijgo_16026 crossref_primary_10_3390_biomedicines12010229 crossref_primary_10_3390_antiox9020133 crossref_primary_10_1097_MJT_0000000000001584 crossref_primary_10_3390_futurepharmacol4030035 crossref_primary_10_1080_01443615_2022_2151352 crossref_primary_10_1159_000513070 crossref_primary_10_3390_ijms21062151 crossref_primary_10_1007_s00129_017_4134_z crossref_primary_10_3892_ol_2023_13912 crossref_primary_10_1016_j_rcl_2023_02_002 crossref_primary_10_1016_j_smhs_2020_10_001 crossref_primary_10_18632_oncotarget_20688 crossref_primary_10_1016_j_ejphar_2024_177157 crossref_primary_10_31083_j_fbl2809220 crossref_primary_10_3390_cancers15245726 crossref_primary_10_1002_adtp_202000144 crossref_primary_10_3390_cancers13235953 crossref_primary_10_1007_s00129_022_05013_5 crossref_primary_10_1097_CAD_0000000000001288 crossref_primary_10_3390_cancers12051175 crossref_primary_10_3390_ijms24087126 crossref_primary_10_1016_j_heliyon_2024_e28442 crossref_primary_10_1186_s12943_017_0638_3 crossref_primary_10_1002_jgm_3233 crossref_primary_10_1007_s00604_019_3588_1 crossref_primary_10_3892_ijo_2024_5664 crossref_primary_10_1038_s41467_018_06434_4 crossref_primary_10_1166_jbn_2024_3774 crossref_primary_10_32948_ajo_2025_01_20 crossref_primary_10_1016_j_crphar_2020_100008 crossref_primary_10_1007_s00404_020_05834_6 crossref_primary_10_2147_CMAR_S242781 crossref_primary_10_1016_j_ajog_2022_05_029 crossref_primary_10_1007_s11033_019_04794_8 crossref_primary_10_31083_j_ceog4907166 crossref_primary_10_1186_s12885_023_11017_8 crossref_primary_10_1007_s11010_024_05168_w crossref_primary_10_1016_j_jep_2025_119474 crossref_primary_10_36074_grail_of_science_14_04_2023_085 crossref_primary_10_1111_cpr_12739 crossref_primary_10_3390_ijms19092543 crossref_primary_10_1038_s41598_022_06788_2 crossref_primary_10_1080_19396368_2022_2101961 crossref_primary_10_2174_0929867327666200819115403 crossref_primary_10_3389_fonc_2022_949766 crossref_primary_10_1155_2023_1951412 crossref_primary_10_1007_s00280_018_3548_1 crossref_primary_10_1016_j_cbi_2018_02_003 crossref_primary_10_1016_j_heliyon_2022_e10399 crossref_primary_10_3390_ijms20040952 crossref_primary_10_12998_wjcc_v12_i11_1967 crossref_primary_10_1007_s10930_022_10047_8 crossref_primary_10_3390_ijms241411455 crossref_primary_10_1016_j_eujim_2020_101227 crossref_primary_10_3390_cancers14122885 crossref_primary_10_1186_s13048_021_00858_1 crossref_primary_10_1080_21655979_2021_2000732 crossref_primary_10_1186_s13048_021_00910_0 crossref_primary_10_1038_s41374_021_00533_5 crossref_primary_10_1021_acsami_2c15143 crossref_primary_10_1097_CM9_0000000000002201 crossref_primary_10_1007_s12325_021_01955_9 crossref_primary_10_1016_j_cbi_2024_110958 crossref_primary_10_3390_nu14010185 crossref_primary_10_1007_s10528_021_10080_9 crossref_primary_10_1148_radiol_211367 crossref_primary_10_2147_OTT_S269983 crossref_primary_10_3390_cancers15123125 crossref_primary_10_3892_ol_2024_14624 crossref_primary_10_3348_kjr_2021_0706 crossref_primary_10_1080_2162402X_2021_1935104 crossref_primary_10_1007_s40471_020_00227_4 crossref_primary_10_1016_j_ygyno_2023_10_018 crossref_primary_10_1111_cbdd_14228 crossref_primary_10_1136_ijgc_2020_001606 crossref_primary_10_1021_acs_molpharmaceut_3c00132 crossref_primary_10_1016_j_lfs_2022_120328 crossref_primary_10_1007_s13577_021_00522_2 crossref_primary_10_1016_j_ygeno_2022_110554 crossref_primary_10_3390_biomedicines10040920 crossref_primary_10_3389_fgene_2021_688207 crossref_primary_10_1016_j_mce_2023_112127 crossref_primary_10_23736_S0026_4806_19_06103_2 crossref_primary_10_2174_1389450121666200425211732 crossref_primary_10_1371_journal_pmed_1002893 crossref_primary_10_3892_or_2017_5879 crossref_primary_10_1002_jbt_23368 crossref_primary_10_3892_ol_2021_13104 crossref_primary_10_1177_15330338211067911 crossref_primary_10_22516_25007440_951 crossref_primary_10_3389_fgene_2022_814291 crossref_primary_10_1177_1533033820980115 crossref_primary_10_3390_ijms21197093 crossref_primary_10_3892_etm_2018_6000 crossref_primary_10_1038_s41420_021_00600_2 crossref_primary_10_1186_s13048_024_01375_7 crossref_primary_10_1136_ijgc_2023_004882 crossref_primary_10_2174_1389201024666221111160407 crossref_primary_10_3389_fcell_2022_832354 crossref_primary_10_1186_s12905_023_02879_y crossref_primary_10_1007_s13205_022_03222_2 crossref_primary_10_1038_s41598_021_96072_6 crossref_primary_10_3390_pharmaceutics13010019 crossref_primary_10_1158_1940_6207_CAPR_21_0324 crossref_primary_10_1007_s10147_024_02559_3 crossref_primary_10_1186_s13048_020_00635_6 crossref_primary_10_1097_01_JAA_0000735800_98948_bb crossref_primary_10_1007_s12032_019_1287_8 crossref_primary_10_3390_cancers15225489 crossref_primary_10_1159_000534064 crossref_primary_10_1080_1061186X_2018_1564923 crossref_primary_10_1002_iid3_534 crossref_primary_10_3390_ijms25158121 crossref_primary_10_1080_13543784_2020_1769065 crossref_primary_10_1016_j_gine_2023_100910 crossref_primary_10_1002_cam4_3907 crossref_primary_10_1055_s_0043_1762925 crossref_primary_10_4236_jct_2023_1410035 crossref_primary_10_1016_j_cpet_2023_12_007 crossref_primary_10_3389_fonc_2021_681396 crossref_primary_10_1038_s41598_025_85466_5 crossref_primary_10_1007_s10495_024_02027_3 crossref_primary_10_1007_s12038_020_00136_0 crossref_primary_10_1080_20742835_2021_1962084 crossref_primary_10_2217_epi_2021_0204 crossref_primary_10_2147_DDDT_S311187 crossref_primary_10_62347_XZRI9189 crossref_primary_10_1007_s10528_022_10227_2 crossref_primary_10_1080_0284186X_2022_2140015 crossref_primary_10_3389_fonc_2024_1483425 crossref_primary_10_1177_1533033820977535 crossref_primary_10_17650_2686_9594_2022_12_3_56_62 crossref_primary_10_1186_s10020_021_00359_3 crossref_primary_10_3390_cimb46030174 crossref_primary_10_1016_j_ijbiomac_2023_123514 crossref_primary_10_1186_s12957_021_02295_2 crossref_primary_10_18632_aging_202601 crossref_primary_10_1097_CAD_0000000000001423 crossref_primary_10_3389_fmolb_2022_838006 crossref_primary_10_1007_s40995_022_01328_z crossref_primary_10_1016_j_arcmed_2022_11_007 crossref_primary_10_1016_j_phymed_2022_154102 crossref_primary_10_1097_MD_0000000000008207 crossref_primary_10_2147_OTT_S244928 crossref_primary_10_3390_biology11010023 crossref_primary_10_1186_s13048_020_00712_w crossref_primary_10_4103_cjop_CJOP_D_22_00142 crossref_primary_10_1016_j_ecoenv_2023_114877 crossref_primary_10_3389_fphar_2021_783317 crossref_primary_10_1016_j_gendis_2023_06_032 crossref_primary_10_18632_aging_103668 crossref_primary_10_1080_14737159_2021_1924680 crossref_primary_10_2174_1389201023666221011115301 crossref_primary_10_1016_j_omtn_2020_08_006 crossref_primary_10_1016_j_gore_2024_101670 crossref_primary_10_1038_s41419_022_05291_w crossref_primary_10_1016_j_ygyno_2021_12_017 crossref_primary_10_1016_j_microc_2020_104746 crossref_primary_10_2174_0118715206282904240122063914 crossref_primary_10_1080_21655979_2021_1978615 crossref_primary_10_1136_jitc_2022_005270 crossref_primary_10_2174_1389450120666190708100308 crossref_primary_10_1016_j_ygyno_2022_09_003 crossref_primary_10_3389_fcell_2021_645647 crossref_primary_10_3389_fmed_2023_1145487 crossref_primary_10_1007_s13258_021_01138_4 crossref_primary_10_3390_ijerph18126629 crossref_primary_10_1016_j_lfs_2022_121328 crossref_primary_10_1371_journal_pone_0255804 crossref_primary_10_3389_fonc_2022_986885 crossref_primary_10_4103_ijmr_IJMR_224_18 crossref_primary_10_1016_j_ejon_2024_102756 crossref_primary_10_1016_j_ygyno_2019_11_004 crossref_primary_10_2174_0109298673280484240101070607 crossref_primary_10_4274_tjod_galenos_2022_59558 crossref_primary_10_1002_cam4_1812 crossref_primary_10_1007_s12015_019_09911_5 crossref_primary_10_1007_s11051_019_4735_7 crossref_primary_10_1007_s12013_020_00939_w crossref_primary_10_3389_fgene_2022_917481 crossref_primary_10_1016_j_compbiomed_2024_108747 crossref_primary_10_3390_ijms21145034 crossref_primary_10_3389_fonc_2022_1057198 crossref_primary_10_2174_0109298673271808231116075056 crossref_primary_10_3389_fonc_2022_811783 crossref_primary_10_3390_ijms23105846 crossref_primary_10_1186_s12889_024_18858_3 crossref_primary_10_1016_j_semcancer_2021_08_008 crossref_primary_10_1097_01_JAA_0000000000000042 crossref_primary_10_3390_pharmaceutics16070902 crossref_primary_10_3390_ijms22126216 crossref_primary_10_1002_biof_1555 crossref_primary_10_1186_s12967_021_03224_3 crossref_primary_10_21294_1814_4861_2022_21_6_145_155 crossref_primary_10_1002_cbin_11709 crossref_primary_10_3390_cancers13164178 crossref_primary_10_3389_fgene_2022_1094474 crossref_primary_10_1007_s00521_023_09231_3 crossref_primary_10_1007_s12032_022_01824_7 crossref_primary_10_1016_j_canep_2018_05_011 crossref_primary_10_1093_carcin_bgad067 crossref_primary_10_2174_0929867327666200713190520 crossref_primary_10_3389_fcell_2021_699487 crossref_primary_10_1016_j_microc_2021_106083 crossref_primary_10_3389_fpubh_2024_1405010 crossref_primary_10_1016_j_ejca_2023_113402 crossref_primary_10_1155_2022_7397250 crossref_primary_10_1016_j_bbcan_2023_188888 crossref_primary_10_1186_s13048_023_01167_5 crossref_primary_10_1007_s40944_020_00391_x crossref_primary_10_1111_1471_0528_17341 crossref_primary_10_7759_cureus_28086 crossref_primary_10_1155_2020_8965459 crossref_primary_10_3390_cancers14164056 crossref_primary_10_1089_cbr_2020_4394 crossref_primary_10_1016_j_diabres_2025_112109 crossref_primary_10_1177_0963689719877372 crossref_primary_10_18632_oncotarget_27845 crossref_primary_10_1186_s13048_021_00822_z crossref_primary_10_2298_SARH240502036S crossref_primary_10_1111_anae_15389 crossref_primary_10_1016_j_sjbs_2019_08_008 crossref_primary_10_5306_wjco_v13_i12_967 crossref_primary_10_1002_wrna_1784 crossref_primary_10_1007_s10565_024_09924_y crossref_primary_10_1186_s13048_023_01275_2 crossref_primary_10_3390_ijms20184533 crossref_primary_10_3389_fonc_2022_971479 crossref_primary_10_1097_CAD_0000000000001373 crossref_primary_10_12688_f1000research_24866_1 crossref_primary_10_3389_fbioe_2022_873369 crossref_primary_10_3390_ijms25158304 crossref_primary_10_1093_biolre_ioac011 crossref_primary_10_1371_journal_pone_0248019 crossref_primary_10_1186_s13046_021_02139_7 crossref_primary_10_3390_cells13010070 crossref_primary_10_1007_s10555_024_10177_8 crossref_primary_10_1155_2022_4041550 crossref_primary_10_62347_IOFY5604 crossref_primary_10_1155_2023_6637414 crossref_primary_10_1001_jamanetworkopen_2022_45141 crossref_primary_10_1111_ajco_13519 crossref_primary_10_1097_MD_0000000000017475 crossref_primary_10_3390_ijms23063036 crossref_primary_10_3390_jpm13081226 crossref_primary_10_3390_molecules26195949 crossref_primary_10_3802_jgo_2019_30_e10 crossref_primary_10_31260_RepertMedCir_01217372_1228 crossref_primary_10_1080_21691401_2019_1687496 crossref_primary_10_1016_j_ygeno_2020_09_011 crossref_primary_10_1186_s43046_022_00111_w crossref_primary_10_1016_j_apt_2021_10_019 crossref_primary_10_1177_03000605211040762 |
| Cites_doi | 10.1093/ije/dyw207 10.1016/j.ygyno.2015.03.016 10.1136/jmedgenet-2013-102015 10.1530/ERC-12-0395 10.1158/1055-9965.EPI-08-0546 10.1200/JCO.2011.39.8545 10.1038/bjc.2014.544 10.1200/JCO.2012.48.2596 10.1016/j.ygyno.2014.07.001 10.1007/s10552-013-0174-4 10.1001/jamainternmed.2016.1548 10.1016/j.fertnstert.2009.10.012 10.1016/j.ygyno.2011.06.038 10.3945/ajcn.113.062794 10.1093/annonc/mdu578 10.1371/journal.pmed.1001200 10.1158/1055-9965.EPI-15-1330 10.1093/jnci/djt431 10.1158/1940-6207.CAPR-13-0037 10.1006/gyno.2002.6674 10.1016/S1470-2045(11)70404-1 10.1111/j.1471-0528.1998.tb10148.x 10.1093/jnci/92.14.1172 10.1007/s10552-009-9402-3 10.1089/bfm.2009.0050 10.1093/jnci/dju208 10.1016/S0140-6736(14)61687-1 10.1097/IGC.0b013e31828189b2 10.1016/j.fertnstert.2013.08.008 10.1093/jnci/92.3.249 10.1200/JCO.2015.61.2408 10.1016/S0140-6736(71)92335-X 10.1093/jnci/djv214 10.1016/j.ygyno.2014.11.012 10.1093/oxfordjournals.aje.a116427 10.1371/journal.pmed.1001182 10.1007/s10552-015-0656-7 10.1677/ERC-08-0075 10.1093/jnci/90.23.1774 10.1200/JCO.2016.66.8178 10.1016/j.ejca.2013.07.005 10.1038/sj.bjc.6603020 10.1016/j.ygyno.2014.01.030 10.1158/1055-9965.EPI-05-0484 10.1002/cncr.23956 10.1093/jnci/djt453 10.1016/S1470-2045(12)70322-4 10.1080/01635581.2011.594208 10.1038/bjc.2011.254 10.1093/ije/dyt042 10.1111/j.1471-0528.2012.03298.x 10.1007/s10552-014-0381-7 10.1016/j.ygyno.2004.07.012 10.1136/bmj.b249 10.1371/journal.pone.0037141 10.1186/1471-2407-13-28 10.1002/1097-0142(19861201)58:11<2363::AID-CNCR2820581102>3.0.CO;2-# 10.1016/j.ejca.2010.04.018 10.1016/j.ygyno.2016.05.014 10.1093/jnci/91.17.1459 10.1002/ijc.29386 10.1158/1055-9965.EPI-16-0011 10.1038/bjc.2011.489 10.1146/annurev.pharmtox.42.082101.154309 10.1002/ijc.2910150411 10.1093/oxfordjournals.aje.a008939 10.1038/bjc.2016.153 10.1038/nrc1408 10.1093/ije/dyw158 10.1016/j.critrevonc.2014.12.012 10.1056/NEJM198703123161102 10.1007/s10552-009-9440-x 10.1016/S0140-6736(08)60167-1 10.1016/j.ygyno.2013.01.027 10.1111/j.1365-2125.2005.02526.x 10.1093/jnci/dju111 10.1002/ijc.27952 10.1016/S0140-6736(99)05203-4 10.1093/aje/155.3.217 |
| ContentType | Journal Article |
| Copyright | 2016 Copyright © 2016. Published by Elsevier Ltd. |
| Copyright_xml | – notice: 2016 – notice: Copyright © 2016. Published by Elsevier Ltd. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1016/j.bpobgyn.2016.08.006 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1532-1932 |
| EndPage | 14 |
| ExternalDocumentID | 27743768 10_1016_j_bpobgyn_2016_08_006 S1521693416300918 1_s2_0_S1521693416300918 |
| Genre | Journal Article Review |
| GroupedDBID | --- --K --M .1- .FO .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 23N 4.4 457 4G. 53G 5GY 5VS 6J9 6PF 7-5 71M 8P~ AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAWTL AAXKI AAXUO AAYWO ABBQC ABMAC ABMZM ABWVN ABXDB ACDAQ ACGFS ACIEU ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO AEBSH AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGUBO AGYEJ AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CAG COF DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-Q GBLVA HVGLF HZ~ IHE J1W KOM M41 MO0 N9A O-L O9- OAUVE OQ. OZT P-8 P-9 P2P PC. PH~ Q38 R2- ROL RPZ SDF SDG SEL SES SPCBC SSH SSZ T5K Z5R ~G- AACTN AFCTW AFKWA AJOXV AMFUW RIG AAIAV ABLVK ABYKQ AJBFU EFLBG LCYCR AAYXX AGRNS CITATION CGR CUY CVF ECM EIF NPM 7X8 ACLOT ~HD |
| ID | FETCH-LOGICAL-c474t-c485c015347a238433f621daf6d832d4cb9fc2d35b3bced788efdf21614f26b33 |
| IEDL.DBID | AIKHN |
| ISSN | 1521-6934 1532-1932 |
| IngestDate | Sun Sep 28 02:18:38 EDT 2025 Mon Jul 21 05:49:24 EDT 2025 Thu Apr 24 23:08:34 EDT 2025 Tue Jul 01 02:42:58 EDT 2025 Fri Feb 23 02:30:22 EST 2024 Tue Feb 25 19:55:09 EST 2025 Tue Aug 26 18:36:48 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | ovarian neoplasms epidemiology risk factors incidence survival Ovarian neoplasms |
| Language | English |
| License | Copyright © 2016. Published by Elsevier Ltd. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c474t-c485c015347a238433f621daf6d832d4cb9fc2d35b3bced788efdf21614f26b33 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| ORCID | 0000-0003-0733-5930 |
| PMID | 27743768 |
| PQID | 1835434369 |
| PQPubID | 23479 |
| PageCount | 12 |
| ParticipantIDs | proquest_miscellaneous_1835434369 pubmed_primary_27743768 crossref_citationtrail_10_1016_j_bpobgyn_2016_08_006 crossref_primary_10_1016_j_bpobgyn_2016_08_006 elsevier_sciencedirect_doi_10_1016_j_bpobgyn_2016_08_006 elsevier_clinicalkeyesjournals_1_s2_0_S1521693416300918 elsevier_clinicalkey_doi_10_1016_j_bpobgyn_2016_08_006 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2017-05-01 |
| PublicationDateYYYYMMDD | 2017-05-01 |
| PublicationDate_xml | – month: 05 year: 2017 text: 2017-05-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Netherlands |
| PublicationPlace_xml | – name: Netherlands |
| PublicationTitle | Best practice & research. Clinical obstetrics & gynaecology |
| PublicationTitleAlternate | Best Pract Res Clin Obstet Gynaecol |
| PublicationYear | 2017 |
| Publisher | Elsevier Ltd |
| Publisher_xml | – name: Elsevier Ltd |
| References | Houghton, Reeves, Hankinson (bib85) 2014; 106 Baandrup, Kjaer, Olsen (bib53) 2015; 26 Bonovas, Filioussi, Sitaras (bib50) 2006; 62 World Cancer Research Fund/American Institute for Cancer Research. Systematic literature review continuous update project report: The associations between food, nutrition and physical activity and the risk of ovarian cancer. London: 2013. Available at Gong, Wu, Vogtmann (bib11) 2013; 132 Beral, Gaitskell (bib36) 2015; 385 Stratton, Pharoah, Smith (bib4) 1998; 105 Whiteman, Murphy, Cook (bib18) 2000; 92 Trabert, Ness, Lo-Ciganic (bib52) 2014; 106 Hildebrand, Gapstur, Gaudet (bib62) 2015; 26 Urban, Banks, Egger (bib34) 2012; 9 Setiawan, Yang, Pike (bib69) 2013; 31 Alsop, Fereday, Meldrum (bib6) 2012; 30 Olsen, Green, Nagle (bib44) 2008; 15 . Seer*Stat Database: Incidence-SEER 18 Regs Research Data+Hurricane Katrina impacted Louisiana Cases, Nov 2015 sub (2000–2013). National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, April 2016. Rizzuto, Behrens, Smith (bib24) 2013; 8 Ji, Sundquist, Sundquist (bib76) 2015; 112 Cannioto, LaMonte, Risch (bib60) 2016; 25 Gertig, Hunter, Cramer (bib84) 2000; 92 Cramer, Welch (bib88) 1983; 71 Ness, DW, Goodman (bib28) 2002; 155 Armstrong, Doll (bib71) 1975; 15 Calle, Kaaks (bib55) 2004; 4 Wentzensen, Poole, Trabert (bib12) 2016; 34 Beral, Gaitskell (bib67) 2012; 13 World Cancer Research Fund/American Institute for Cancer Research (bib80) 2013 Boyd (bib7) 2003; 88 Ramus, Song, Dicks (bib9) 2015; 107 Pearce, Templeman, Rossing (bib41) 2012; 13 Ferlay J, Bray F, Steliarova-Foucher E, et al. Cancer incidence in five continents, CI5plus. IARC CancerBase No. 9. Lyon: International Agency for Research on Cancer; 2014. Available from The Cancer Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development (bib32) 1987; 316 Au-Yeung, Webb, Defazio (bib92) 2014; 133 Faber, Kjaer, Dehlendorff (bib68) 2013; 24 Key, Appleby (bib63) 2011; 105 Jervis, Song, Lee (bib5) 2014; 51 Ness, Cottreau (bib45) 1999; 91 Terry, Karageorgi, Shvetsov (bib83) 2013; 6 Jensen, Sharif, Frederiksen (bib26) 2009; 338 Tsoref, Panzarella, Oza (bib64) 2014; 106 Mills, Riordan, Cress (bib15) 2004; 95 Pearce, Chung, Pike (bib37) 2009; 115 Genkinger, Hunter, Spiegelman (bib65) 2006; 94 Genkinger, Hunter, Spiegelman (bib75) 2006; 15 Wilailak, Vipupinyo, Suraseranivong (bib33) 2012; 119 Soini, Hurskainen, Grenman (bib35) 2016 World Cancer Research Fund/American Institute for Cancer Research. Continuous update project report. Food, nutrition, physical activity, and the prevention of ovarian cancer. 2014. Available at Moore, Lee, Weiderpass (bib61) 2016; 176 Trabert, Lamb, Scoccia (bib29) 2013; 100 Tokuoka, Kawai, Shimizu (bib86) 1987; 79 McGuire, Hartge, Liao (bib17) 2016; 25 Dixon, Nagle, Thrift (bib58) 2016 Braem, Onland-Moret, Schouten (bib20) 2012; 7 Parkin, Boyd, Walker (bib91) 2011; 105 accessed 14 July 2016. Baandrup, Friis, Dehlendorff (bib51) 2014; 106 Surveillance Epidemiology and End Results (SEER) Program Olsen, Nagle, Whiteman (bib57) 2013; 20 Rose, Boyar, Wynder (bib72) 1986; 58 Risch (bib89) 1998; 90 Ip, Chung, Raman (bib21) 2009; 4 Whittemore, Harris, Itnyre (bib13) 1992; 136 Rasmussen, Kjaer, Albieri (bib46) 2016 Zhang, Binns, Lee (bib82) 2002; 11 Brinton, Moghissi, Westhoff (bib42) 2010; 94 Whiteman, Webb, Green (bib90) 2015; 39 Beral, Doll (bib30) 2008; 371 (bib56) 2012; 9 Westhoff, Gentile, Lee (bib70) 1996; 144 Luan, Wu, Gong (bib22) 2013; 98 Lynch, Casey, Lynch (bib8) 1998; 25 Venn, Watson, Bruinsma (bib25) 1999; 354 Stewart, Holman, Finn (bib27) 2013; 129 Gottschau, Kjaer, Jensen (bib43) 2015; 136 Poole, Konstantinopoulos, Terry (bib94) 2016 Brunner, Wactawski-Wende, Caan (bib78) 2011; 63 Fathalla (bib87) 1971; 2 Iodice, Barile, Rotmensz (bib31) 2010; 46 Antoniou, Rookus, Andrieu (bib39) 2009; 18 Song, Dicks, Ramus (bib10) 2015; 33 Cannioto, LaMonte, Kelemen (bib93) 2016; 115 Kelemen, Bandera, Terry (bib66) 2013; 13 Bodmer, Becker, Meier (bib49) 2011; 123 Jordan, Siskind, A (bib23) 2010; 21 Merritt, Poole, Hankinson (bib77) 2014; 25 Dick, Siskind, Purdie (bib19) 2009; 20 Jordan, Nagle, Coory (bib40) 2013; 49 Whiteman, Siskind, Purdie (bib16) 2003; 12 Kotsopoulos, Lubinski, Gronwald (bib14) 2015; 137 Bouillet, Bigard, Brami (bib95) 2015; 94 Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancerbase No. 11 [internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from Chen, Chang, Ko (bib48) 2014; 134 Sieh, Salvador, McGuire (bib38) 2013; 42 Merritt, Tzoulaki, van den Brandt (bib74) 2015 Cannioto, Moysich (bib59) 2015; 137 Ong, Cuellar-Partida, Lu (bib79) 2016 Yang, Maliakal, Meng (bib81) 2002; 42 Lee, Jeon, Kim (bib47) 2013; 23 10.1016/j.bpobgyn.2016.08.006_bib54 Calle (10.1016/j.bpobgyn.2016.08.006_bib55) 2004; 4 Merritt (10.1016/j.bpobgyn.2016.08.006_bib74) 2015 Yang (10.1016/j.bpobgyn.2016.08.006_bib81) 2002; 42 Beral (10.1016/j.bpobgyn.2016.08.006_bib36) 2015; 385 Chen (10.1016/j.bpobgyn.2016.08.006_bib48) 2014; 134 Gottschau (10.1016/j.bpobgyn.2016.08.006_bib43) 2015; 136 Pearce (10.1016/j.bpobgyn.2016.08.006_bib41) 2012; 13 Jensen (10.1016/j.bpobgyn.2016.08.006_bib26) 2009; 338 Parkin (10.1016/j.bpobgyn.2016.08.006_bib91) 2011; 105 Ji (10.1016/j.bpobgyn.2016.08.006_bib76) 2015; 112 Boyd (10.1016/j.bpobgyn.2016.08.006_bib7) 2003; 88 Jervis (10.1016/j.bpobgyn.2016.08.006_bib5) 2014; 51 Moore (10.1016/j.bpobgyn.2016.08.006_bib61) 2016; 176 Gertig (10.1016/j.bpobgyn.2016.08.006_bib84) 2000; 92 Merritt (10.1016/j.bpobgyn.2016.08.006_bib77) 2014; 25 Whittemore (10.1016/j.bpobgyn.2016.08.006_bib13) 1992; 136 Ness (10.1016/j.bpobgyn.2016.08.006_bib28) 2002; 155 Lynch (10.1016/j.bpobgyn.2016.08.006_bib8) 1998; 25 Cramer (10.1016/j.bpobgyn.2016.08.006_bib88) 1983; 71 Braem (10.1016/j.bpobgyn.2016.08.006_bib20) 2012; 7 Jordan (10.1016/j.bpobgyn.2016.08.006_bib40) 2013; 49 Soini (10.1016/j.bpobgyn.2016.08.006_bib35) 2016 Stewart (10.1016/j.bpobgyn.2016.08.006_bib27) 2013; 129 Setiawan (10.1016/j.bpobgyn.2016.08.006_bib69) 2013; 31 Dixon (10.1016/j.bpobgyn.2016.08.006_bib58) 2016 Faber (10.1016/j.bpobgyn.2016.08.006_bib68) 2013; 24 Wilailak (10.1016/j.bpobgyn.2016.08.006_bib33) 2012; 119 Zhang (10.1016/j.bpobgyn.2016.08.006_bib82) 2002; 11 Tsoref (10.1016/j.bpobgyn.2016.08.006_bib64) 2014; 106 Key (10.1016/j.bpobgyn.2016.08.006_bib63) 2011; 105 Trabert (10.1016/j.bpobgyn.2016.08.006_bib29) 2013; 100 Whiteman (10.1016/j.bpobgyn.2016.08.006_bib18) 2000; 92 Bodmer (10.1016/j.bpobgyn.2016.08.006_bib49) 2011; 123 Bonovas (10.1016/j.bpobgyn.2016.08.006_bib50) 2006; 62 Mills (10.1016/j.bpobgyn.2016.08.006_bib15) 2004; 95 Olsen (10.1016/j.bpobgyn.2016.08.006_bib44) 2008; 15 Ong (10.1016/j.bpobgyn.2016.08.006_bib79) 2016 Rizzuto (10.1016/j.bpobgyn.2016.08.006_bib24) 2013; 8 Cannioto (10.1016/j.bpobgyn.2016.08.006_bib93) 2016; 115 Armstrong (10.1016/j.bpobgyn.2016.08.006_bib71) 1975; 15 Sieh (10.1016/j.bpobgyn.2016.08.006_bib38) 2013; 42 Baandrup (10.1016/j.bpobgyn.2016.08.006_bib53) 2015; 26 Fathalla (10.1016/j.bpobgyn.2016.08.006_bib87) 1971; 2 Trabert (10.1016/j.bpobgyn.2016.08.006_bib52) 2014; 106 Wentzensen (10.1016/j.bpobgyn.2016.08.006_bib12) 2016; 34 Genkinger (10.1016/j.bpobgyn.2016.08.006_bib65) 2006; 94 Stratton (10.1016/j.bpobgyn.2016.08.006_bib4) 1998; 105 Ip (10.1016/j.bpobgyn.2016.08.006_bib21) 2009; 4 Brunner (10.1016/j.bpobgyn.2016.08.006_bib78) 2011; 63 Poole (10.1016/j.bpobgyn.2016.08.006_bib94) 2016 Whiteman (10.1016/j.bpobgyn.2016.08.006_bib16) 2003; 12 10.1016/j.bpobgyn.2016.08.006_bib73 The Cancer Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development (10.1016/j.bpobgyn.2016.08.006_bib32) 1987; 316 Rose (10.1016/j.bpobgyn.2016.08.006_bib72) 1986; 58 Luan (10.1016/j.bpobgyn.2016.08.006_bib22) 2013; 98 Hildebrand (10.1016/j.bpobgyn.2016.08.006_bib62) 2015; 26 Risch (10.1016/j.bpobgyn.2016.08.006_bib89) 1998; 90 Venn (10.1016/j.bpobgyn.2016.08.006_bib25) 1999; 354 Urban (10.1016/j.bpobgyn.2016.08.006_bib34) 2012; 9 Ness (10.1016/j.bpobgyn.2016.08.006_bib45) 1999; 91 McGuire (10.1016/j.bpobgyn.2016.08.006_bib17) 2016; 25 Beral (10.1016/j.bpobgyn.2016.08.006_bib30) 2008; 371 Antoniou (10.1016/j.bpobgyn.2016.08.006_bib39) 2009; 18 Song (10.1016/j.bpobgyn.2016.08.006_bib10) 2015; 33 Gong (10.1016/j.bpobgyn.2016.08.006_bib11) 2013; 132 Beral (10.1016/j.bpobgyn.2016.08.006_bib67) 2012; 13 Bouillet (10.1016/j.bpobgyn.2016.08.006_bib95) 2015; 94 Iodice (10.1016/j.bpobgyn.2016.08.006_bib31) 2010; 46 Westhoff (10.1016/j.bpobgyn.2016.08.006_bib70) 1996; 144 10.1016/j.bpobgyn.2016.08.006_bib1 Terry (10.1016/j.bpobgyn.2016.08.006_bib83) 2013; 6 10.1016/j.bpobgyn.2016.08.006_bib2 Baandrup (10.1016/j.bpobgyn.2016.08.006_bib51) 2014; 106 (10.1016/j.bpobgyn.2016.08.006_bib56) 2012; 9 Genkinger (10.1016/j.bpobgyn.2016.08.006_bib75) 2006; 15 10.1016/j.bpobgyn.2016.08.006_bib3 Alsop (10.1016/j.bpobgyn.2016.08.006_bib6) 2012; 30 Brinton (10.1016/j.bpobgyn.2016.08.006_bib42) 2010; 94 Olsen (10.1016/j.bpobgyn.2016.08.006_bib57) 2013; 20 Kelemen (10.1016/j.bpobgyn.2016.08.006_bib66) 2013; 13 Pearce (10.1016/j.bpobgyn.2016.08.006_bib37) 2009; 115 Lee (10.1016/j.bpobgyn.2016.08.006_bib47) 2013; 23 Ramus (10.1016/j.bpobgyn.2016.08.006_bib9) 2015; 107 Cannioto (10.1016/j.bpobgyn.2016.08.006_bib59) 2015; 137 World Cancer Research Fund/American Institute for Cancer Research (10.1016/j.bpobgyn.2016.08.006_bib80) 2013 Whiteman (10.1016/j.bpobgyn.2016.08.006_bib90) 2015; 39 Au-Yeung (10.1016/j.bpobgyn.2016.08.006_bib92) 2014; 133 Rasmussen (10.1016/j.bpobgyn.2016.08.006_bib46) 2016 Tokuoka (10.1016/j.bpobgyn.2016.08.006_bib86) 1987; 79 Houghton (10.1016/j.bpobgyn.2016.08.006_bib85) 2014; 106 Kotsopoulos (10.1016/j.bpobgyn.2016.08.006_bib14) 2015; 137 Dick (10.1016/j.bpobgyn.2016.08.006_bib19) 2009; 20 Jordan (10.1016/j.bpobgyn.2016.08.006_bib23) 2010; 21 Cannioto (10.1016/j.bpobgyn.2016.08.006_bib60) 2016; 25 |
| References_xml | – volume: 33 start-page: 2901 year: 2015 end-page: 2907 ident: bib10 article-title: Contribution of germline mutations in the RAD51B, RAD51C, and RAD51D genes to ovarian cancer in the population publication-title: J Clin Oncol – volume: 88 start-page: S8 year: 2003 end-page: S10 ident: bib7 article-title: Specific keynote: hereditary ovarian cancer: what we know publication-title: Gynecol Oncol – volume: 62 start-page: 113 year: 2006 end-page: 121 ident: bib50 article-title: Paracetamol use and risk of ovarian cancer: a meta-analysis publication-title: Br J Clin Pharmacol – volume: 9 start-page: e1001182 year: 2012 ident: bib34 article-title: Injectable and oral contraceptive use and cancers of the breast, cervix, ovary, and endometrium in black South African women: case–control study publication-title: PLoS Med – volume: 137 start-page: 1136 year: 2015 end-page: 1146 ident: bib14 article-title: Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers publication-title: Int J Cancer – volume: 98 start-page: 1020 year: 2013 end-page: 1031 ident: bib22 article-title: Breastfeeding and ovarian cancer risk: a meta-analysis of epidemiologic studies publication-title: Am J Clin Nutr – volume: 90 start-page: 1774 year: 1998 end-page: 1786 ident: bib89 article-title: Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone publication-title: J Natl Cancer Inst – volume: 338 start-page: b249 year: 2009 ident: bib26 article-title: Use of fertility drugs and risk of ovarian cancer: Danish population based cohort study publication-title: Br Med Journal – volume: 31 start-page: 2607 year: 2013 end-page: 2618 ident: bib69 article-title: Type I and II endometrial cancers: have they different risk factors? publication-title: J Clin Oncol – volume: 25 start-page: 1114 year: 2016 end-page: 1124 ident: bib60 article-title: Chronic recreational physical inactivity and epithelial ovarian cancer risk: evidence from the Ovarian Cancer Association Consortium publication-title: Cancer Epidemiol Biomarkers Prev – volume: 23 start-page: 402 year: 2013 end-page: 412 ident: bib47 article-title: Diabetes mellitus and ovarian cancer risk: a systematic review and meta-analysis of observational studies publication-title: Int J Gynecol Cancer – volume: 25 start-page: 795 year: 2014 end-page: 808 ident: bib77 article-title: Dairy food and nutrient intake in different life periods in relation to risk of ovarian cancer publication-title: Cancer Causes Control – volume: 79 start-page: 47 year: 1987 end-page: 57 ident: bib86 article-title: Malignant and benign ovarian neoplasms among atomic bomb survivors, Hiroshima and Nagasaki publication-title: J Natl Cancer Inst – volume: 21 start-page: 109 year: 2010 end-page: 116 ident: bib23 article-title: Breastfeeding and risk of epithelial ovarian cancer publication-title: Cancer Causes Control – volume: 92 start-page: 249 year: 2000 end-page: 252 ident: bib84 article-title: Prospective study of talc use and ovarian cancer publication-title: J Natl Cancer Inst – volume: 7 start-page: e37141 year: 2012 ident: bib20 article-title: Multiple miscarriages are associated with the risk of ovarian cancer: results from the European Prospective Investigation into Cancer and Nutrition publication-title: PLoS One – volume: 132 start-page: 2894 year: 2013 end-page: 2900 ident: bib11 article-title: Age at menarche and risk of ovarian cancer: a meta-analysis of epidemiological studies publication-title: Int J Cancer – volume: 42 start-page: 579 year: 2013 end-page: 589 ident: bib38 article-title: Tubal ligation and the risk of ovarian cancer subtypes publication-title: Int J Epidemiol – volume: 94 start-page: 757 year: 2006 end-page: 762 ident: bib65 article-title: Alcohol intake and ovarian cancer risk: a pooled analysis of 10 cohort studies publication-title: Br J Cancer – reference: , accessed 14 July 2016. – year: 2016 ident: bib79 article-title: Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study publication-title: Int J Epidemiol – volume: 106 start-page: djt431 year: 2014 ident: bib52 article-title: Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium publication-title: J Natl Cancer Inst – reference: World Cancer Research Fund/American Institute for Cancer Research. Systematic literature review continuous update project report: The associations between food, nutrition and physical activity and the risk of ovarian cancer. London: 2013. Available at – volume: 94 start-page: 1787 year: 2010 end-page: 1792 ident: bib42 article-title: Cancer risk among infertile women with androgen excess or menstrual disorders (including polycystic ovary syndrome) publication-title: Fertil Steril – volume: 13 start-page: 28 year: 2013 ident: bib66 article-title: Recent alcohol consumption and risk of incident ovarian carcinoma: a pooled analysis of 5,342 cases and 10,358 controls from the Ovarian Cancer Association Consortium publication-title: BMC Cancer – year: 2016 ident: bib46 article-title: Pelvic inflammatory disease and risk of ovarian cancer and borderline ovarian tumors: a pooled analysis of 13 case-control studies publication-title: Am J Epidemiol – year: 2016 ident: bib58 article-title: Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study publication-title: Int J Epidemiol – volume: 18 start-page: 601 year: 2009 end-page: 610 ident: bib39 article-title: Reproductive and hormonal factors, and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: results from the international BRCA1/2 carrier cohort study publication-title: Cancer Epidemiol Biomarkers Prev – volume: 13 start-page: 385 year: 2012 end-page: 394 ident: bib41 article-title: Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies publication-title: Lancet Oncol – volume: 15 start-page: 1061 year: 2008 end-page: 1068 ident: bib44 article-title: Epithelial ovarian cancer: testing the ‘androgens hypothesis’ publication-title: Endocr Relat Cancer – volume: 4 start-page: 579 year: 2004 end-page: 591 ident: bib55 article-title: Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms publication-title: Nat Rev Cancer – volume: 49 start-page: 3638 year: 2013 end-page: 3647 ident: bib40 article-title: Has the association between hysterectomy and ovarian cancer changed over time? A systematic review and meta-analysis publication-title: Eur J Cancer – volume: 71 start-page: 717 year: 1983 end-page: 721 ident: bib88 article-title: Determinants of ovarian cancer risk. ii. Inferences regarding pathogenesis publication-title: J Natl Cancer Inst – volume: 95 start-page: 215 year: 2004 end-page: 225 ident: bib15 article-title: Epithelial ovarian cancer risk by invasiveness and cell type in the central valley of California publication-title: Gynecol Oncol – volume: 15 start-page: 364 year: 2006 end-page: 372 ident: bib75 article-title: Dairy products and ovarian cancer: a pooled analysis of 12 cohort studies publication-title: Cancer Epidemiol Biomarkers Prev – volume: 371 start-page: 303 year: 2008 end-page: 314 ident: bib30 article-title: Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls publication-title: Lancet – volume: 42 start-page: 25 year: 2002 end-page: 54 ident: bib81 article-title: Inhibition of carcinogenesis by tea publication-title: Ann Rev Pharmacol Toxicol – volume: 123 start-page: 200 year: 2011 end-page: 204 ident: bib49 article-title: Use of metformin and the risk of ovarian cancer: a case-control analysis publication-title: Gynecol Oncol – volume: 385 start-page: 1835 year: 2015 end-page: 1842 ident: bib36 article-title: Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies publication-title: Lancet – volume: 115 start-page: 95 year: 2016 end-page: 101 ident: bib93 article-title: Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the Ovarian Cancer Association Consortium publication-title: Br J Cancer – volume: 30 start-page: 2654 year: 2012 end-page: 2663 ident: bib6 article-title: BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group publication-title: J Clin Oncol – volume: 25 start-page: 265 year: 1998 end-page: 280 ident: bib8 article-title: Genetics and ovarian carcinoma publication-title: Semin Oncol – reference: Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancerbase No. 11 [internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: – volume: 8 start-page: CD008215 year: 2013 ident: bib24 article-title: Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility publication-title: Cochrane Database Syst Rev – volume: 13 start-page: 946 year: 2012 end-page: 956 ident: bib67 article-title: Ovarian cancer and smoking: individual participant meta-analysis including 28,114 women with ovarian cancer from 51 epidemiological studies publication-title: Lancet Oncol – volume: 58 start-page: 2363 year: 1986 end-page: 2371 ident: bib72 article-title: International comparisons of mortality rates for cancer of the breast, ovary, prostate and colon, and per capita food consumption publication-title: Cancer – volume: 39 start-page: 477 year: 2015 end-page: 484 ident: bib90 article-title: Cancers in Australia in 2010 attributable to modifiable factors: summary and conclusions publication-title: ANZ J Publ Health – volume: 112 start-page: 149 year: 2015 end-page: 152 ident: bib76 article-title: Lactose intolerance and risk of lung, breast and ovarian cancers: aetiological clues from a population-based study in Sweden publication-title: Br J Cancer – year: 2013 ident: bib80 article-title: Continuous update project report. Food, nutrition, physical activity and the prevention of endometrial cancer – volume: 105 start-page: S77 year: 2011 end-page: S81 ident: bib91 article-title: 16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010 publication-title: Br J Cancer – volume: 6 start-page: 811 year: 2013 end-page: 821 ident: bib83 article-title: Genital powder use and risk of ovarian cancer: a pooled analysis of 8,525 cases and 9,859 controls publication-title: Cancer Prev Res – volume: 2 start-page: 163 year: 1971 ident: bib87 article-title: Incessant ovulation-a factor in ovarian neoplasia? publication-title: Lancet – volume: 51 start-page: 108 year: 2014 end-page: 113 ident: bib5 article-title: Ovarian cancer familial relative risks by tumour subtypes and by known ovarian cancer genetic susceptibility variants publication-title: J Med Genet – volume: 34 start-page: 2888 year: 2016 end-page: 2898 ident: bib12 article-title: Ovarian cancer risk factors by histologic subtype: an analysis from the Ovarian Cancer Cohort Consortium publication-title: J Clin Oncol – volume: 105 start-page: 709 year: 2011 end-page: 722 ident: bib63 article-title: Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies publication-title: Br J Cancer – reference: Ferlay J, Bray F, Steliarova-Foucher E, et al. Cancer incidence in five continents, CI5plus. IARC CancerBase No. 9. Lyon: International Agency for Research on Cancer; 2014. Available from: – reference: Surveillance Epidemiology and End Results (SEER) Program ( – volume: 94 start-page: 74 year: 2015 end-page: 86 ident: bib95 article-title: Role of physical activity and sport in oncology: scientific commission of the national federation sport and cancer CAMI publication-title: Crit Rev Oncol Hematol – volume: 20 start-page: 1571 year: 2009 end-page: 1585 ident: bib19 article-title: Incomplete pregnancy and risk of ovarian cancer: results from two Australian case-control studies and systematic review publication-title: Cancer Causes Control – reference: World Cancer Research Fund/American Institute for Cancer Research. Continuous update project report. Food, nutrition, physical activity, and the prevention of ovarian cancer. 2014. Available at – volume: 100 start-page: 1660 year: 2013 end-page: 1666 ident: bib29 article-title: Ovulation-inducing drugs and ovarian cancer risk: results from an extended follow-up of a large United States infertility cohort publication-title: Fertil Steril – volume: 137 start-page: 559 year: 2015 end-page: 573 ident: bib59 article-title: Epithelial ovarian cancer and recreational physical activity: a review of the epidemiological literature and implications for exercise prescription publication-title: Gynecol Oncol – volume: 176 start-page: 816 year: 2016 end-page: 825 ident: bib61 article-title: Association of leisure-time physical activity with risk of 26 types of cancer in 1.44 million adults publication-title: JAMA Internal Medicine – volume: 24 start-page: 989 year: 2013 end-page: 1004 ident: bib68 article-title: Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case-control studies publication-title: Cancer Causes Control – volume: 136 start-page: 1184 year: 1992 end-page: 1203 ident: bib13 article-title: Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. ii. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group publication-title: Am J Epidemiol – volume: 354 start-page: 1586 year: 1999 end-page: 1590 ident: bib25 article-title: Risk of cancer after use of fertility drugs with in-vitro fertilisation publication-title: Lancet – volume: 46 start-page: 2275 year: 2010 end-page: 2284 ident: bib31 article-title: Oral contraceptive use and breast or ovarian cancer risk in brca1/2 carriers: a meta-analysis publication-title: Eur J Cancer – volume: 134 start-page: 576 year: 2014 end-page: 580 ident: bib48 article-title: A large scale population-based cohort study on the risk of ovarian neoplasm in patients with type 2 diabetes mellitus publication-title: Gynecol Oncol – volume: 144 start-page: 381 year: 1996 end-page: 388 ident: bib70 article-title: Predictors of ovarian steroid secretion in reproductive-age women publication-title: Am J Epidemiol – volume: 155 start-page: 217 year: 2002 end-page: 224 ident: bib28 article-title: Infertility, fertility drugs and ovarian cancer: a pooled analysis of case-control studies publication-title: Am J Epidemiol – volume: 15 start-page: 617 year: 1975 end-page: 631 ident: bib71 article-title: Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices publication-title: Int J Cancer – year: 2016 ident: bib94 article-title: Prognostic implications of reproductive and lifestyle factors in ovarian cancer publication-title: Gynecol Oncol – volume: 12 start-page: 42 year: 2003 end-page: 46 ident: bib16 article-title: Timing of pregnancy and the risk of epithelial ovarian cancer publication-title: Cancer Epidemiol Biomarkers Prev – volume: 106 start-page: dju208 year: 2014 ident: bib85 article-title: Perineal powder use and risk of ovarian cancer publication-title: J Natl Cancer Inst – volume: 119 start-page: 672 year: 2012 end-page: 677 ident: bib33 article-title: Depot medroxyprogesterone acetate and epithelial ovarian cancer: a multicentre case-control study publication-title: Br J Obstet Gynaecol – volume: 107 year: 2015 ident: bib9 article-title: Germline mutations in the BRIP1, BARD1, PALB2, and NBN genes in women with ovarian cancer publication-title: J Natl Cancer Inst – volume: 92 start-page: 1172 year: 2000 end-page: 1177 ident: bib18 article-title: Multiple births and risk of epithelial ovarian cancer publication-title: J Natl Cancer Inst – volume: 316 start-page: 650 year: 1987 end-page: 655 ident: bib32 article-title: The reduction in risk of ovarian cancer associated with oral-contraceptive use publication-title: New Engl J Med – volume: 26 start-page: 1691 year: 2015 end-page: 1697 ident: bib62 article-title: Moderate-to-vigorous physical activity and leisure-time sitting in relation to ovarian cancer risk in a large prospective us cohort publication-title: Cancer Causes Control – volume: 9 start-page: e1001200 year: 2012 ident: bib56 article-title: Ovarian cancer and body size: individual participant meta-analysis including 25157 women with ovarian cancer from 47 epidemiological studies publication-title: PLoS Medicine – volume: 20 start-page: 251 year: 2013 end-page: 262 ident: bib57 article-title: Obesity and risk of ovarian cancer subtypes: evidence from the Ovrian Cancer Association Consortium publication-title: Endocr Relat Cancer – reference: ). Seer*Stat Database: Incidence-SEER 18 Regs Research Data+Hurricane Katrina impacted Louisiana Cases, Nov 2015 sub (2000–2013). National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, April 2016. – volume: 91 start-page: 1459 year: 1999 end-page: 1467 ident: bib45 article-title: Possible role of ovarian epithelial inflammation in ovarian cancer publication-title: J Natl Cancer Inst – volume: 106 start-page: dju111 year: 2014 ident: bib51 article-title: Prescription use of paracetamol and risk for ovarian cancer in Denmark publication-title: J Natl Cancer Inst – year: 2015 ident: bib74 article-title: Nutrient-wide association study of 57 foods/nutrients and epithelial ovarian cancer in the European Prospective Investigation into Cancer and Nutrition Study and the Netherlands Cohort Study publication-title: Am J Clin Nutr – volume: 25 start-page: 1059 year: 2016 end-page: 1063 ident: bib17 article-title: Parity and oral contraceptive use in relation to ovarian cancer risk in older women publication-title: Cancer Epidemiol Biomarkers Prev – volume: 4 start-page: S17 year: 2009 end-page: S30 ident: bib21 article-title: A summary of the agency for healthcare research and quality's evidence report on breastfeeding in developed countries publication-title: Breastfeed Med – volume: 129 start-page: 372 year: 2013 end-page: 376 ident: bib27 article-title: In vitro fertilization is associated with an increased risk of borderline ovarian tumours publication-title: Gynecol Oncol – reference: . – volume: 106 start-page: djt453 year: 2014 ident: bib64 article-title: Aspirin in prevention of ovarian cancer: are we at the tipping point? publication-title: J Natl Cancer Inst – volume: 63 start-page: 827 year: 2011 end-page: 841 ident: bib78 article-title: The effect of calcium plus vitamin D on risk for invasive cancer: results of the Women's Health Initiative (WHI) calcium plus vitamin D randomized clinical trial publication-title: Nutr Cancer – volume: 136 start-page: 99 year: 2015 end-page: 103 ident: bib43 article-title: Risk of cancer among women with polycystic ovary syndrome: a Danish cohort study publication-title: Gynecol Oncol – volume: 133 start-page: 16 year: 2014 end-page: 22 ident: bib92 article-title: Impact of obesity on chemotherapy dosing for women with advanced stage serous ovarian cancer in the Australian Ovarian Cancer Study publication-title: Gynecol Oncol – volume: 105 start-page: 493 year: 1998 end-page: 499 ident: bib4 article-title: A systematic review and meta-analysis of family history and risk of ovarian cancer publication-title: Br J Obstet Gynaecol – year: 2016 ident: bib35 article-title: Impact of levonorgestrel-releasing intrauterine system use on the cancer risk of the ovary and fallopian tube publication-title: Acta Oncol – volume: 115 start-page: 531 year: 2009 end-page: 539 ident: bib37 article-title: Increased ovarian cancer risk associated with menopausal estrogen therapy is reduced by adding a progestin publication-title: Cancer – volume: 11 start-page: 713 year: 2002 end-page: 718 ident: bib82 article-title: Tea consumption and ovarian cancer risk: a case-control study in China publication-title: Cancer Epidemiol Biomarkers Prev – volume: 26 start-page: 787 year: 2015 end-page: 792 ident: bib53 article-title: Low-dose aspirin use and the risk of ovarian cancer in Denmark publication-title: Ann Oncol – year: 2016 ident: 10.1016/j.bpobgyn.2016.08.006_bib79 article-title: Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study publication-title: Int J Epidemiol doi: 10.1093/ije/dyw207 – volume: 137 start-page: 559 issue: 3 year: 2015 ident: 10.1016/j.bpobgyn.2016.08.006_bib59 article-title: Epithelial ovarian cancer and recreational physical activity: a review of the epidemiological literature and implications for exercise prescription publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2015.03.016 – volume: 51 start-page: 108 issue: 2 year: 2014 ident: 10.1016/j.bpobgyn.2016.08.006_bib5 article-title: Ovarian cancer familial relative risks by tumour subtypes and by known ovarian cancer genetic susceptibility variants publication-title: J Med Genet doi: 10.1136/jmedgenet-2013-102015 – volume: 20 start-page: 251 issue: 2 year: 2013 ident: 10.1016/j.bpobgyn.2016.08.006_bib57 article-title: Obesity and risk of ovarian cancer subtypes: evidence from the Ovrian Cancer Association Consortium publication-title: Endocr Relat Cancer doi: 10.1530/ERC-12-0395 – volume: 18 start-page: 601 issue: 2 year: 2009 ident: 10.1016/j.bpobgyn.2016.08.006_bib39 article-title: Reproductive and hormonal factors, and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: results from the international BRCA1/2 carrier cohort study publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-08-0546 – volume: 30 start-page: 2654 issue: 21 year: 2012 ident: 10.1016/j.bpobgyn.2016.08.006_bib6 article-title: BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group publication-title: J Clin Oncol doi: 10.1200/JCO.2011.39.8545 – volume: 12 start-page: 42 issue: 1 year: 2003 ident: 10.1016/j.bpobgyn.2016.08.006_bib16 article-title: Timing of pregnancy and the risk of epithelial ovarian cancer publication-title: Cancer Epidemiol Biomarkers Prev – volume: 112 start-page: 149 issue: 1 year: 2015 ident: 10.1016/j.bpobgyn.2016.08.006_bib76 article-title: Lactose intolerance and risk of lung, breast and ovarian cancers: aetiological clues from a population-based study in Sweden publication-title: Br J Cancer doi: 10.1038/bjc.2014.544 – volume: 31 start-page: 2607 issue: 20 year: 2013 ident: 10.1016/j.bpobgyn.2016.08.006_bib69 article-title: Type I and II endometrial cancers: have they different risk factors? publication-title: J Clin Oncol doi: 10.1200/JCO.2012.48.2596 – volume: 134 start-page: 576 issue: 3 year: 2014 ident: 10.1016/j.bpobgyn.2016.08.006_bib48 article-title: A large scale population-based cohort study on the risk of ovarian neoplasm in patients with type 2 diabetes mellitus publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2014.07.001 – volume: 24 start-page: 989 issue: 5 year: 2013 ident: 10.1016/j.bpobgyn.2016.08.006_bib68 article-title: Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case-control studies publication-title: Cancer Causes Control doi: 10.1007/s10552-013-0174-4 – volume: 176 start-page: 816 issue: 6 year: 2016 ident: 10.1016/j.bpobgyn.2016.08.006_bib61 article-title: Association of leisure-time physical activity with risk of 26 types of cancer in 1.44 million adults publication-title: JAMA Internal Medicine doi: 10.1001/jamainternmed.2016.1548 – volume: 94 start-page: 1787 issue: 5 year: 2010 ident: 10.1016/j.bpobgyn.2016.08.006_bib42 article-title: Cancer risk among infertile women with androgen excess or menstrual disorders (including polycystic ovary syndrome) publication-title: Fertil Steril doi: 10.1016/j.fertnstert.2009.10.012 – volume: 123 start-page: 200 issue: 2 year: 2011 ident: 10.1016/j.bpobgyn.2016.08.006_bib49 article-title: Use of metformin and the risk of ovarian cancer: a case-control analysis publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2011.06.038 – volume: 79 start-page: 47 issue: 1 year: 1987 ident: 10.1016/j.bpobgyn.2016.08.006_bib86 article-title: Malignant and benign ovarian neoplasms among atomic bomb survivors, Hiroshima and Nagasaki publication-title: J Natl Cancer Inst – volume: 98 start-page: 1020 issue: 4 year: 2013 ident: 10.1016/j.bpobgyn.2016.08.006_bib22 article-title: Breastfeeding and ovarian cancer risk: a meta-analysis of epidemiologic studies publication-title: Am J Clin Nutr doi: 10.3945/ajcn.113.062794 – volume: 26 start-page: 787 issue: 4 year: 2015 ident: 10.1016/j.bpobgyn.2016.08.006_bib53 article-title: Low-dose aspirin use and the risk of ovarian cancer in Denmark publication-title: Ann Oncol doi: 10.1093/annonc/mdu578 – volume: 9 start-page: e1001200 issue: 4 year: 2012 ident: 10.1016/j.bpobgyn.2016.08.006_bib56 article-title: Ovarian cancer and body size: individual participant meta-analysis including 25157 women with ovarian cancer from 47 epidemiological studies publication-title: PLoS Medicine doi: 10.1371/journal.pmed.1001200 – volume: 25 start-page: 1114 issue: 7 year: 2016 ident: 10.1016/j.bpobgyn.2016.08.006_bib60 article-title: Chronic recreational physical inactivity and epithelial ovarian cancer risk: evidence from the Ovarian Cancer Association Consortium publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-15-1330 – volume: 106 start-page: djt431 issue: 2 year: 2014 ident: 10.1016/j.bpobgyn.2016.08.006_bib52 article-title: Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djt431 – volume: 6 start-page: 811 issue: 8 year: 2013 ident: 10.1016/j.bpobgyn.2016.08.006_bib83 article-title: Genital powder use and risk of ovarian cancer: a pooled analysis of 8,525 cases and 9,859 controls publication-title: Cancer Prev Res doi: 10.1158/1940-6207.CAPR-13-0037 – volume: 88 start-page: S8 issue: 1 Pt 2 year: 2003 ident: 10.1016/j.bpobgyn.2016.08.006_bib7 article-title: Specific keynote: hereditary ovarian cancer: what we know publication-title: Gynecol Oncol doi: 10.1006/gyno.2002.6674 – volume: 13 start-page: 385 year: 2012 ident: 10.1016/j.bpobgyn.2016.08.006_bib41 article-title: Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies publication-title: Lancet Oncol doi: 10.1016/S1470-2045(11)70404-1 – ident: 10.1016/j.bpobgyn.2016.08.006_bib2 – volume: 105 start-page: 493 issue: 5 year: 1998 ident: 10.1016/j.bpobgyn.2016.08.006_bib4 article-title: A systematic review and meta-analysis of family history and risk of ovarian cancer publication-title: Br J Obstet Gynaecol doi: 10.1111/j.1471-0528.1998.tb10148.x – volume: 92 start-page: 1172 issue: 14 year: 2000 ident: 10.1016/j.bpobgyn.2016.08.006_bib18 article-title: Multiple births and risk of epithelial ovarian cancer publication-title: J Natl Cancer Inst doi: 10.1093/jnci/92.14.1172 – volume: 20 start-page: 1571 issue: 9 year: 2009 ident: 10.1016/j.bpobgyn.2016.08.006_bib19 article-title: Incomplete pregnancy and risk of ovarian cancer: results from two Australian case-control studies and systematic review publication-title: Cancer Causes Control doi: 10.1007/s10552-009-9402-3 – volume: 4 start-page: S17 issue: Suppl. 1 year: 2009 ident: 10.1016/j.bpobgyn.2016.08.006_bib21 article-title: A summary of the agency for healthcare research and quality's evidence report on breastfeeding in developed countries publication-title: Breastfeed Med doi: 10.1089/bfm.2009.0050 – volume: 106 start-page: dju208 issue: 9 year: 2014 ident: 10.1016/j.bpobgyn.2016.08.006_bib85 article-title: Perineal powder use and risk of ovarian cancer publication-title: J Natl Cancer Inst doi: 10.1093/jnci/dju208 – year: 2016 ident: 10.1016/j.bpobgyn.2016.08.006_bib35 article-title: Impact of levonorgestrel-releasing intrauterine system use on the cancer risk of the ovary and fallopian tube publication-title: Acta Oncol – volume: 385 start-page: 1835 issue: 9980 year: 2015 ident: 10.1016/j.bpobgyn.2016.08.006_bib36 article-title: Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies publication-title: Lancet doi: 10.1016/S0140-6736(14)61687-1 – volume: 23 start-page: 402 issue: 3 year: 2013 ident: 10.1016/j.bpobgyn.2016.08.006_bib47 article-title: Diabetes mellitus and ovarian cancer risk: a systematic review and meta-analysis of observational studies publication-title: Int J Gynecol Cancer doi: 10.1097/IGC.0b013e31828189b2 – volume: 100 start-page: 1660 issue: 6 year: 2013 ident: 10.1016/j.bpobgyn.2016.08.006_bib29 article-title: Ovulation-inducing drugs and ovarian cancer risk: results from an extended follow-up of a large United States infertility cohort publication-title: Fertil Steril doi: 10.1016/j.fertnstert.2013.08.008 – volume: 25 start-page: 265 issue: 3 year: 1998 ident: 10.1016/j.bpobgyn.2016.08.006_bib8 article-title: Genetics and ovarian carcinoma publication-title: Semin Oncol – volume: 92 start-page: 249 issue: 3 year: 2000 ident: 10.1016/j.bpobgyn.2016.08.006_bib84 article-title: Prospective study of talc use and ovarian cancer publication-title: J Natl Cancer Inst doi: 10.1093/jnci/92.3.249 – volume: 33 start-page: 2901 issue: 26 year: 2015 ident: 10.1016/j.bpobgyn.2016.08.006_bib10 article-title: Contribution of germline mutations in the RAD51B, RAD51C, and RAD51D genes to ovarian cancer in the population publication-title: J Clin Oncol doi: 10.1200/JCO.2015.61.2408 – volume: 2 start-page: 163 issue: 7716 year: 1971 ident: 10.1016/j.bpobgyn.2016.08.006_bib87 article-title: Incessant ovulation-a factor in ovarian neoplasia? publication-title: Lancet doi: 10.1016/S0140-6736(71)92335-X – volume: 107 issue: 11 year: 2015 ident: 10.1016/j.bpobgyn.2016.08.006_bib9 article-title: Germline mutations in the BRIP1, BARD1, PALB2, and NBN genes in women with ovarian cancer publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djv214 – volume: 136 start-page: 99 issue: 1 year: 2015 ident: 10.1016/j.bpobgyn.2016.08.006_bib43 article-title: Risk of cancer among women with polycystic ovary syndrome: a Danish cohort study publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2014.11.012 – volume: 136 start-page: 1184 issue: 10 year: 1992 ident: 10.1016/j.bpobgyn.2016.08.006_bib13 article-title: Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. ii. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group publication-title: Am J Epidemiol doi: 10.1093/oxfordjournals.aje.a116427 – volume: 9 start-page: e1001182 issue: 3 year: 2012 ident: 10.1016/j.bpobgyn.2016.08.006_bib34 article-title: Injectable and oral contraceptive use and cancers of the breast, cervix, ovary, and endometrium in black South African women: case–control study publication-title: PLoS Med doi: 10.1371/journal.pmed.1001182 – volume: 26 start-page: 1691 issue: 11 year: 2015 ident: 10.1016/j.bpobgyn.2016.08.006_bib62 article-title: Moderate-to-vigorous physical activity and leisure-time sitting in relation to ovarian cancer risk in a large prospective us cohort publication-title: Cancer Causes Control doi: 10.1007/s10552-015-0656-7 – ident: 10.1016/j.bpobgyn.2016.08.006_bib73 – volume: 15 start-page: 1061 issue: 4 year: 2008 ident: 10.1016/j.bpobgyn.2016.08.006_bib44 article-title: Epithelial ovarian cancer: testing the ‘androgens hypothesis’ publication-title: Endocr Relat Cancer doi: 10.1677/ERC-08-0075 – volume: 90 start-page: 1774 issue: 23 year: 1998 ident: 10.1016/j.bpobgyn.2016.08.006_bib89 article-title: Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone publication-title: J Natl Cancer Inst doi: 10.1093/jnci/90.23.1774 – volume: 34 start-page: 2888 issue: 24 year: 2016 ident: 10.1016/j.bpobgyn.2016.08.006_bib12 article-title: Ovarian cancer risk factors by histologic subtype: an analysis from the Ovarian Cancer Cohort Consortium publication-title: J Clin Oncol doi: 10.1200/JCO.2016.66.8178 – volume: 49 start-page: 3638 issue: 17 year: 2013 ident: 10.1016/j.bpobgyn.2016.08.006_bib40 article-title: Has the association between hysterectomy and ovarian cancer changed over time? A systematic review and meta-analysis publication-title: Eur J Cancer doi: 10.1016/j.ejca.2013.07.005 – year: 2016 ident: 10.1016/j.bpobgyn.2016.08.006_bib46 article-title: Pelvic inflammatory disease and risk of ovarian cancer and borderline ovarian tumors: a pooled analysis of 13 case-control studies publication-title: Am J Epidemiol – ident: 10.1016/j.bpobgyn.2016.08.006_bib1 – volume: 94 start-page: 757 issue: 5 year: 2006 ident: 10.1016/j.bpobgyn.2016.08.006_bib65 article-title: Alcohol intake and ovarian cancer risk: a pooled analysis of 10 cohort studies publication-title: Br J Cancer doi: 10.1038/sj.bjc.6603020 – volume: 133 start-page: 16 issue: 1 year: 2014 ident: 10.1016/j.bpobgyn.2016.08.006_bib92 article-title: Impact of obesity on chemotherapy dosing for women with advanced stage serous ovarian cancer in the Australian Ovarian Cancer Study publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2014.01.030 – volume: 15 start-page: 364 issue: 2 year: 2006 ident: 10.1016/j.bpobgyn.2016.08.006_bib75 article-title: Dairy products and ovarian cancer: a pooled analysis of 12 cohort studies publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-05-0484 – volume: 115 start-page: 531 issue: 3 year: 2009 ident: 10.1016/j.bpobgyn.2016.08.006_bib37 article-title: Increased ovarian cancer risk associated with menopausal estrogen therapy is reduced by adding a progestin publication-title: Cancer doi: 10.1002/cncr.23956 – volume: 106 start-page: djt453 issue: 2 year: 2014 ident: 10.1016/j.bpobgyn.2016.08.006_bib64 article-title: Aspirin in prevention of ovarian cancer: are we at the tipping point? publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djt453 – volume: 13 start-page: 946 issue: 9 year: 2012 ident: 10.1016/j.bpobgyn.2016.08.006_bib67 article-title: Ovarian cancer and smoking: individual participant meta-analysis including 28,114 women with ovarian cancer from 51 epidemiological studies publication-title: Lancet Oncol doi: 10.1016/S1470-2045(12)70322-4 – volume: 63 start-page: 827 issue: 6 year: 2011 ident: 10.1016/j.bpobgyn.2016.08.006_bib78 article-title: The effect of calcium plus vitamin D on risk for invasive cancer: results of the Women's Health Initiative (WHI) calcium plus vitamin D randomized clinical trial publication-title: Nutr Cancer doi: 10.1080/01635581.2011.594208 – volume: 105 start-page: 709 issue: 5 year: 2011 ident: 10.1016/j.bpobgyn.2016.08.006_bib63 article-title: Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies publication-title: Br J Cancer doi: 10.1038/bjc.2011.254 – volume: 42 start-page: 579 year: 2013 ident: 10.1016/j.bpobgyn.2016.08.006_bib38 article-title: Tubal ligation and the risk of ovarian cancer subtypes publication-title: Int J Epidemiol doi: 10.1093/ije/dyt042 – volume: 119 start-page: 672 issue: 6 year: 2012 ident: 10.1016/j.bpobgyn.2016.08.006_bib33 article-title: Depot medroxyprogesterone acetate and epithelial ovarian cancer: a multicentre case-control study publication-title: Br J Obstet Gynaecol doi: 10.1111/j.1471-0528.2012.03298.x – volume: 25 start-page: 795 issue: 7 year: 2014 ident: 10.1016/j.bpobgyn.2016.08.006_bib77 article-title: Dairy food and nutrient intake in different life periods in relation to risk of ovarian cancer publication-title: Cancer Causes Control doi: 10.1007/s10552-014-0381-7 – volume: 95 start-page: 215 issue: 1 year: 2004 ident: 10.1016/j.bpobgyn.2016.08.006_bib15 article-title: Epithelial ovarian cancer risk by invasiveness and cell type in the central valley of California publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2004.07.012 – year: 2013 ident: 10.1016/j.bpobgyn.2016.08.006_bib80 – volume: 338 start-page: b249 year: 2009 ident: 10.1016/j.bpobgyn.2016.08.006_bib26 article-title: Use of fertility drugs and risk of ovarian cancer: Danish population based cohort study publication-title: Br Med Journal doi: 10.1136/bmj.b249 – volume: 7 start-page: e37141 issue: 5 year: 2012 ident: 10.1016/j.bpobgyn.2016.08.006_bib20 article-title: Multiple miscarriages are associated with the risk of ovarian cancer: results from the European Prospective Investigation into Cancer and Nutrition publication-title: PLoS One doi: 10.1371/journal.pone.0037141 – volume: 13 start-page: 28 year: 2013 ident: 10.1016/j.bpobgyn.2016.08.006_bib66 article-title: Recent alcohol consumption and risk of incident ovarian carcinoma: a pooled analysis of 5,342 cases and 10,358 controls from the Ovarian Cancer Association Consortium publication-title: BMC Cancer doi: 10.1186/1471-2407-13-28 – volume: 58 start-page: 2363 year: 1986 ident: 10.1016/j.bpobgyn.2016.08.006_bib72 article-title: International comparisons of mortality rates for cancer of the breast, ovary, prostate and colon, and per capita food consumption publication-title: Cancer doi: 10.1002/1097-0142(19861201)58:11<2363::AID-CNCR2820581102>3.0.CO;2-# – volume: 46 start-page: 2275 issue: 12 year: 2010 ident: 10.1016/j.bpobgyn.2016.08.006_bib31 article-title: Oral contraceptive use and breast or ovarian cancer risk in brca1/2 carriers: a meta-analysis publication-title: Eur J Cancer doi: 10.1016/j.ejca.2010.04.018 – year: 2016 ident: 10.1016/j.bpobgyn.2016.08.006_bib94 article-title: Prognostic implications of reproductive and lifestyle factors in ovarian cancer publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2016.05.014 – volume: 91 start-page: 1459 issue: 17 year: 1999 ident: 10.1016/j.bpobgyn.2016.08.006_bib45 article-title: Possible role of ovarian epithelial inflammation in ovarian cancer publication-title: J Natl Cancer Inst doi: 10.1093/jnci/91.17.1459 – volume: 137 start-page: 1136 issue: 5 year: 2015 ident: 10.1016/j.bpobgyn.2016.08.006_bib14 article-title: Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers publication-title: Int J Cancer doi: 10.1002/ijc.29386 – ident: 10.1016/j.bpobgyn.2016.08.006_bib54 – volume: 25 start-page: 1059 issue: 7 year: 2016 ident: 10.1016/j.bpobgyn.2016.08.006_bib17 article-title: Parity and oral contraceptive use in relation to ovarian cancer risk in older women publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-16-0011 – volume: 39 start-page: 477 year: 2015 ident: 10.1016/j.bpobgyn.2016.08.006_bib90 article-title: Cancers in Australia in 2010 attributable to modifiable factors: summary and conclusions publication-title: ANZ J Publ Health – volume: 105 start-page: S77 issue: Suppl. 2 year: 2011 ident: 10.1016/j.bpobgyn.2016.08.006_bib91 article-title: 16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010 publication-title: Br J Cancer doi: 10.1038/bjc.2011.489 – volume: 42 start-page: 25 year: 2002 ident: 10.1016/j.bpobgyn.2016.08.006_bib81 article-title: Inhibition of carcinogenesis by tea publication-title: Ann Rev Pharmacol Toxicol doi: 10.1146/annurev.pharmtox.42.082101.154309 – volume: 71 start-page: 717 issue: 4 year: 1983 ident: 10.1016/j.bpobgyn.2016.08.006_bib88 article-title: Determinants of ovarian cancer risk. ii. Inferences regarding pathogenesis publication-title: J Natl Cancer Inst – volume: 15 start-page: 617 issue: 4 year: 1975 ident: 10.1016/j.bpobgyn.2016.08.006_bib71 article-title: Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices publication-title: Int J Cancer doi: 10.1002/ijc.2910150411 – volume: 144 start-page: 381 issue: 4 year: 1996 ident: 10.1016/j.bpobgyn.2016.08.006_bib70 article-title: Predictors of ovarian steroid secretion in reproductive-age women publication-title: Am J Epidemiol doi: 10.1093/oxfordjournals.aje.a008939 – volume: 115 start-page: 95 issue: 1 year: 2016 ident: 10.1016/j.bpobgyn.2016.08.006_bib93 article-title: Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the Ovarian Cancer Association Consortium publication-title: Br J Cancer doi: 10.1038/bjc.2016.153 – volume: 11 start-page: 713 issue: 8 year: 2002 ident: 10.1016/j.bpobgyn.2016.08.006_bib82 article-title: Tea consumption and ovarian cancer risk: a case-control study in China publication-title: Cancer Epidemiol Biomarkers Prev – volume: 8 start-page: CD008215 year: 2013 ident: 10.1016/j.bpobgyn.2016.08.006_bib24 article-title: Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility publication-title: Cochrane Database Syst Rev – volume: 4 start-page: 579 issue: 8 year: 2004 ident: 10.1016/j.bpobgyn.2016.08.006_bib55 article-title: Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms publication-title: Nat Rev Cancer doi: 10.1038/nrc1408 – year: 2016 ident: 10.1016/j.bpobgyn.2016.08.006_bib58 article-title: Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study publication-title: Int J Epidemiol doi: 10.1093/ije/dyw158 – year: 2015 ident: 10.1016/j.bpobgyn.2016.08.006_bib74 article-title: Nutrient-wide association study of 57 foods/nutrients and epithelial ovarian cancer in the European Prospective Investigation into Cancer and Nutrition Study and the Netherlands Cohort Study publication-title: Am J Clin Nutr – volume: 94 start-page: 74 issue: 1 year: 2015 ident: 10.1016/j.bpobgyn.2016.08.006_bib95 article-title: Role of physical activity and sport in oncology: scientific commission of the national federation sport and cancer CAMI publication-title: Crit Rev Oncol Hematol doi: 10.1016/j.critrevonc.2014.12.012 – volume: 316 start-page: 650 issue: 11 year: 1987 ident: 10.1016/j.bpobgyn.2016.08.006_bib32 article-title: The reduction in risk of ovarian cancer associated with oral-contraceptive use publication-title: New Engl J Med doi: 10.1056/NEJM198703123161102 – volume: 21 start-page: 109 issue: 1 year: 2010 ident: 10.1016/j.bpobgyn.2016.08.006_bib23 article-title: Breastfeeding and risk of epithelial ovarian cancer publication-title: Cancer Causes Control doi: 10.1007/s10552-009-9440-x – volume: 371 start-page: 303 issue: 9609 year: 2008 ident: 10.1016/j.bpobgyn.2016.08.006_bib30 article-title: Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls publication-title: Lancet doi: 10.1016/S0140-6736(08)60167-1 – volume: 129 start-page: 372 issue: 2 year: 2013 ident: 10.1016/j.bpobgyn.2016.08.006_bib27 article-title: In vitro fertilization is associated with an increased risk of borderline ovarian tumours publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2013.01.027 – volume: 62 start-page: 113 issue: 1 year: 2006 ident: 10.1016/j.bpobgyn.2016.08.006_bib50 article-title: Paracetamol use and risk of ovarian cancer: a meta-analysis publication-title: Br J Clin Pharmacol doi: 10.1111/j.1365-2125.2005.02526.x – ident: 10.1016/j.bpobgyn.2016.08.006_bib3 – volume: 106 start-page: dju111 issue: 6 year: 2014 ident: 10.1016/j.bpobgyn.2016.08.006_bib51 article-title: Prescription use of paracetamol and risk for ovarian cancer in Denmark publication-title: J Natl Cancer Inst doi: 10.1093/jnci/dju111 – volume: 132 start-page: 2894 issue: 12 year: 2013 ident: 10.1016/j.bpobgyn.2016.08.006_bib11 article-title: Age at menarche and risk of ovarian cancer: a meta-analysis of epidemiological studies publication-title: Int J Cancer doi: 10.1002/ijc.27952 – volume: 354 start-page: 1586 year: 1999 ident: 10.1016/j.bpobgyn.2016.08.006_bib25 article-title: Risk of cancer after use of fertility drugs with in-vitro fertilisation publication-title: Lancet doi: 10.1016/S0140-6736(99)05203-4 – volume: 155 start-page: 217 issue: 3 year: 2002 ident: 10.1016/j.bpobgyn.2016.08.006_bib28 article-title: Infertility, fertility drugs and ovarian cancer: a pooled analysis of case-control studies publication-title: Am J Epidemiol doi: 10.1093/aje/155.3.217 |
| SSID | ssj0033925 |
| Score | 2.6478586 |
| SecondaryResourceType | review_article |
| Snippet | Globally, ovarian cancer is the seventh most common cancer in women and the eighth most common cause of cancer death, with five-year survival rates below 45%.... Abstract Globally, ovarian cancer is the seventh most common cancer in women and the eighth most common cause of cancer death, with five-year survival rates... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 3 |
| SubjectTerms | Carcinoma, Ovarian Epithelial epidemiology Female Humans incidence Life Expectancy Neoplasms, Glandular and Epithelial - epidemiology Neoplasms, Glandular and Epithelial - mortality Obstetrics and Gynecology ovarian neoplasms Ovarian Neoplasms - epidemiology Ovarian Neoplasms - etiology Ovarian Neoplasms - mortality risk factors survival Survival Rate |
| Title | Epidemiology of epithelial ovarian cancer |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1521693416300918 https://www.clinicalkey.es/playcontent/1-s2.0-S1521693416300918 https://dx.doi.org/10.1016/j.bpobgyn.2016.08.006 https://www.ncbi.nlm.nih.gov/pubmed/27743768 https://www.proquest.com/docview/1835434369 |
| Volume | 41 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NS8MwFH_oBPEifjs_RgUvHrqlSZpmRxnK_ETUwW6haRtRpB1uCl78233p0g1xonjJIfBI-fWX93tt8t4DOBQyiLNIJj6qm_SRFMbXJJY-0ZGhOGDQYP9DXl2Lbo-f98P-HHSqXBh7rdL5_rFPL721m2k5NFuDx8fWnVUe0WY2osBAIZDzsEBR7WUNFo7PLrrXlUNmOBmWZVNp4FuDaSJP66mpB4V-eLeVUANRFvO0vY9mS9RPIWgpRacrsOxiSO94_JirMJfla7B45U7J1-HoZNr29d0rjJcNbObFM1LNK97w4zjOvcS-7ZcN6J2e3He6vmuJ4Cc84iMcZZiggjMexSi2nDEjaJDGRqS4NVOe6LZJaMpCzTQiiN-3mUkN4hRwQ4VmbBNqeZFn2-ChLNk8UyJTRnhKSdug0ichIxqnSdyuA69QUImrF27bVjyr6mLYk3LgKQuesu0siahDc2I2GBfM-M1AVBCrKhsU_ZdCl_6bYTTLMBu6XThUgRpSRdQ3ptRBTiy_kO0vix5ULFC4Ee3pSpxnxSsuZn-hMc4EIrc1pscEAIpBNnpyufP_hXdhidqIorxruQe10ctrto_x0Eg3YL75ETSQ9Z3by5uGY_8nJ4cIRA |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT-MwEB5BkRYuK950eWUlLnsIdWzHcY8IgcqjvSxI3Kw4iREIJRVtV-q_35nUKUKAQFxysDRy9GU832fHMwNwpHSUFonOQmQ3HaJTuNCyVIfMJo7jA0UDnUP2B6p3Ky_v4rsFOG1yYehapY_9s5heR2s_0vFodoYPD52_xDyqK0hRoFCI9CIsSWpq3YKlk4ur3qAJyAIlQFyXTeVRSAYviTydx2M7rOz9lCqhRqou5km9j96nqI8kaE1F56vw02vI4GT2mmuwUJTr8KPv_5JvwJ-zl7av06ByQTGkzIsndLWg-oeb47QMMvraz5twe352c9oLfUuEMJOJHONTxxkyuJBJimQrhXCKR3nqVI5LM5eZ7bqM5yK2wiKCuL8tXO4Qp0g6rqwQW9Aqq7LYgQBpifJMmc4FkzlnXYdMn8WCWRxmabcNskHBZL5eOLWteDLNxbBH48EzBJ6hdpZMteF4bjacFcz4zEA1EJsmGxTjl8GQ_plh8p5hMfKrcGQiM-KGmTee0gY9t3zlbF-Z9HfjBQYXIv1dScuimuBkdIQmpFCI3PbMPeYAcBTZGMn1r-9PfAjLvZv-tbm-GFztwgondVHfu9yD1vh5UuyjNhrbA-_7_wEbbAiV |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Epidemiology+of+epithelial+ovarian+cancer&rft.jtitle=Best+practice+%26+research.+Clinical+obstetrics+%26+gynaecology&rft.au=Webb%2C+Penelope+M&rft.au=Jordan%2C+Susan+J&rft.date=2017-05-01&rft.issn=1521-6934&rft_id=info:doi/10.1016%2Fj.bpobgyn.2016.08.006&rft.externalDBID=ECK1-s2.0-S1521693416300918&rft.externalDocID=1_s2_0_S1521693416300918 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1521-6934&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1521-6934&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1521-6934&client=summon |